Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies
Date: 2001-05-22
Institutions: Council of the European Union, European Parliament
Subjects: animal nutrition, bovine spongiform encephalopathy, consumer protection, disease prevention, export (EU), health control, health risk, market approval, veterinary inspection

31.5.2001

EN

Official Journal of the European Communities

L 147/1

I

(Acts whose publication is obligatory)

REGULATION (EC) No 999/2001 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL

of 22 May 2001

laying down rules for the prevention, control and eradication of certain transmissible spongiform
encephalopathies

THE EUROPEAN PARLIAMENT AND THE COUNCIL OF THE
EUROPEAN UNION,

Having regard to the Treaty establishing the European
Community, and in particular Article 152(4)(b) thereof,

Having regard to the proposal from the Commission (1),

Having regard to the opinion of the Economic and Social
Committee (2),

Having consulted the Committee of the Regions,

Acting in accordance with the procedure laid down in Article
251 of the Treaty (3),

Whereas:

(1)

(2)

Several distinct
transmissible spongiform encephalo-
pathies (TSEs) have for a number of years been recog-
nised as occurring separately in humans and animals.
Bovine spongiform encephalopathy (BSE) was
first
recognised in bovine animals in 1986 and in the
following years was recognised as occurring in other
species of animal. A new variant of Creutzfeldt-Jakob
Disease (CJD) was described in 1996. Evidence continues
to grow of the similarity between the BSE agent and that
of the new variant of Creutzfeld-Jakob Disease.

Since 1990 the Community has adopted a series of
measures to protect human and animal health from the
risk of BSE. Those measures have been based on the
safeguard provisions of Directives on animal-health
measures. It is appropriate, in view of the magnitude of
the risk posed to human and animal health by certain
TSEs, to adopt specific rules for their prevention, control
and eradication.

(1) OJ C 45, 19.2.1999, p. 2 and
OJ C 120 E, 24.4.2001, p. 89.

(2) OJ C 258, 10.9.1999, p. 19.
(3) Opinion of the European Parliament of 17 May 2000 (OJ C 59,
23.2.2001, p. 93), Common Position of the Council of 12 February
2001 (OJ C 88, 19.3.2001, p. 1) and Decision of the European
Parliament of 3 May 2001.

(3)

(4)

(5)

(6)

(7)

This Regulation directly concerns public health and is
relevant to the functioning of the internal market. It
covers products which are included in Annex I to the
Treaty as well as products which are not. Consequently,
it
the
is appropriate to choose Article 152(4)(b) of
Treaty as the legal basis.

The Commission has obtained scientific opinions,
in
particular from the Scientific Steering Committee and
the Scientific Committee on Veterinary Measures relating
to Public Health, on several aspects of TSEs. Those opin-
ions include advice on measures to reduce the potential
risk for humans and animals resulting from exposure to
infected animal products.

These rules should apply to the production and placing
on the market of live animals and products of animal
origin. However, it is not necessary for them to apply to
cosmetic or medicinal products, medical devices or their
starting materials or intermediate products, for which
in particular on the non-use of
other specific rules,
specified risk material, apply. Nor should they apply to
products of animal origin which do not pose a risk to
animal or human health since they are intended for
purposes other than the production of food, feed or
fertiliser. It is appropriate to ensure that products of
animal origin excluded from the scope of this Regulation
are kept separate from those covered by it unless they
meet at least the same health standards as the latter.

Provision should be made for safeguard measures to be
taken by the Commission in cases where a risk from a
TSE has not been adequately addressed by the
competent authority of a Member State or third country.

A procedure should be established for the determination
of the epidemiological status of a Member State, a third
country and of one of their regions, hereinafter referred
to as ‘countries or regions’ with respect to BSE, on the
basis of the incident propagation and human exposure

L 147/2

EN

Official Journal of the European Communities

31.5.2001

risk, using information available. Member States and
third countries which choose not to apply for their
status to be determined should be classified in a category
by the Commission on the basis of all the information
available to it.

such. Owners should be compensated, as soon as
possible, for the loss of animals and products of animal
origin destroyed pursuant to this Regulation.

(8)

(9)

(10)

Member States should institute education programmes
for those involved in the prevention and control of TSEs,
farmers and workers
as well as
involved in the transportation, marketing and slaughter
of farm animals.

for veterinarians,

Member States should carry out an annual programme
for monitoring BSE and scrapie and should inform the
Commission and the other Member States of the results
and of the emergence of any other TSE.

Certain ruminant tissues should be designated as speci-
fied risk material on the basis of the pathogenesis of
TSEs and the epidemiological status of the country or
region of origin or residence of the animal concerned.
The specified risk material should be removed and
disposed of
in a manner which avoids any risk to
human or animal health. In particular, it should not be
placed on the market to be used in the production of
food, feed or fertiliser. However, provision should be
made for an equivalent level of health protection by
means of a screening test for TSEs carried out on indi-
vidual animals as soon as it has been fully validated.
Slaughter techniques presenting a risk of causing brain
material
to contaminate other tissues should not be
permitted in countries or regions other than those
presenting the lowest risk of BSE.

(11) Measures should be taken to prevent the transmission of
TSEs to humans or animals by prohibiting the feeding of
certain categories of animal protein to certain categories
of animal, and by prohibiting the use of certain rumi-
nant materials in food. Those prohibitions should be
proportionate to the risks involved.

(12)

The suspected presence of any TSE in any animal should
be notified to the competent authority, which should
immediately take all appropriate measures,
including
placing the suspect animal under movement restrictions
while awaiting the results of the investigation or having
it
the
competent authority cannot exclude the possibility of a
TSE, it should have the appropriate investigations carried
out and should keep the carcasse under official super-
vision until a diagnosis has been made.

slaughtered under official

supervision.

If

(13)

In the event of official confirmation of the presence of a
TSE, the competent authority should take all the neces-
sary measures, including having the carcasse destroyed,
carrying out an investigation in order to identify all
animals at risk and placing movement restrictions on the
animals and the products of animal origin identified as

(14) Member States should draw up contingency plans for
the national measures to be implemented in the event of
an outbreak of BSE. Those plans should be approved by
for
the Commission. Provision should be made
extending this provision to TSEs other than BSE.

(15)

(16)

(17)

(18)

Provisions should be laid down covering the placing on
the market of certain live animals and products of
animal origin. Existing Community rules on the identifi-
cation and registration of bovine animals provide for a
system enabling the animals to be traced back to the
dam and herd of origin in accordance with international
standards. Equivalent guarantees should be provided for
bovine animals imported from third countries. The
animals and products of animal origin covered by
Community rules, moving in intra-Community trade or
imported from third countries, should be accompanied
by the certificates required by the said rules, supple-
mented as
in accordance with this
Regulation.

appropriate

The placing on the market of certain products of animal
origin derived from bovine animals in high risk regions
should be prohibited. However, that prohibition should
not apply to certain products of animal origin produced
under controlled conditions from animals which can be
demonstrated not to pose a high risk of infection with a
TSE.

in order

is necessary,

to ensure that

the rules
It
concerning the prevention, control and eradication of
TSEs are observed, for samples to be taken for labora-
tory testing on the basis of an established protocol
which would give a full epidemiological picture of the
situation as regards TSE. In order to guarantee uniform
testing procedures and results, national and Community
Reference Laboratories and reliable scientific methods,
including rapid tests specifically for TSEs, should be
established. Rapid tests should be used as far as possible.

Community inspections should be carried out in the
Member States in order to ensure uniform implementa-
tion of
the requirements concerning the prevention,
control and eradication of TSEs and provision should
also be made for the implementation of audit proced-
ures. In order to ensure that guarantees equivalent to
those applied by the Community are provided by third
countries upon import
live
animals and products of animal origin, Community
on-the-spot inspections and audits should be carried out
in order to verify that the import conditions are met by
exporting third countries.

into the Community of

31.5.2001

EN

Official Journal of the European Communities

L 147/3

(19)

(20)

(21)

(22)

(23)

standards, guidelines or

Trade measures for TSEs should be based on inter-
national
recommendations,
where they exist. However, scientifically justified meas-
ures resulting in a higher level of health protection may
be adopted if measures based on the relevant inter-
recommendations
national
would not achieve the appropriate level of health
protection.

standards, guidelines or

This Regulation should be re-examined as new scientific
information becomes available.

The necessary transitional measures in particular for
regulating the use of specified risk material should be
provided for in the framework of this Regulation.

The measures necessary for the implementation of this
Regulation should be adopted in accordance with
Council Decision 1999/468/EC of 28 June 1999 laying
down the procedure for the exercise of implementing
powers conferred on the Commission (1).

to implement

this Regulation, procedures
In order
should be laid down establishing close and effective
cooperation between the Commission and the Member
States within the Standing Veterinary Committee, the
Standing Committee on Feedingstuffs, and the Standing
Committee on Foodstuffs.

(24) Given that the provisions for the implementation of this
Regulation are general measures within the meaning of
they should be
Article 2 of Decision 1999/468/EC,
adopted in accordance with the regulatory procedure
laid down in Article 5 of that Decision,

HAVE ADOPTED THIS REGULATION:

CHAPTER I

GENERAL PROVISIONS

Article 1

Scope

1.
This Regulation lays down rules for the prevention,
control and eradication of transmissible spongiform encephalo-
pathies (TSEs) in animals. It shall apply to the production and
placing on the market of live animals and products of animal
origin and in certain specific cases to exports thereof.

2.

This Regulation shall not apply to:

(a) cosmetic or medicinal products or medical devices, or to

their starting materials or intermediate products;

(1) OJ L 184, 17.7.1999, p. 23.

(b) products which are not intended for use in human food,
animal feed or fertilisers, or to their starting materials or
intermediate products;

(c) products of animal origin intended for exhibition, teaching,
scientific research, special studies or analysis, provided
those products are not eventually consumed or used by
humans or by animals other than those kept
for the
research projects concerned;

(d) live animals used in or intended for research.

Article 2

Separation of live animals and of products of animal
origin

In order to avoid cross-contamination or substitution between
the live animals or of the products of animal origin referred to
in Article 1(1) and the products of animal origin referred to in
Article 1(2)(a), (b) and (c), or the live animals referred to in
Article 1(2)(d), they shall be kept separate at all times unless
such live animals or products of animal origin are produced
under at least the same conditions of health protection in
respect of TSEs.

Rules for the implementation of this Article shall be adopted in
accordance with the procedure referred to in Article 24(2).

Article 3

Definitions

For the purposes of this Regulation the following defini-

1.
tions shall apply:

(a) TSEs: all transmissible spongiform encephalopathies with

the exception of those occurring in humans;

(b) placing on the market: any operation the purpose of
which is to sell live animals or products of animal origin
covered by this Regulation to a third party in the
Community, or any other form of supply against payment
or free of charge to such a third party or storage with a
view to supply to such a third party;

(c) products of animal origin: any product derived from or
containing a product derived from any animal covered by
the provisions of Directive 89/662/EEC (2) or Directive
90/425/EEC (3);

(d) starting materials: raw materials or any other product of
animal origin out of which, or with the help of which, the
products referred to in Article 1(2)(a) and (b) are produced;

(e) competent authority: the central authority of a Member
State competent to ensure compliance with the require-
ments of this Regulation or any authority to which that
central authority has delegated that competence, in partic-
ular for the control of feedingstuffs; it shall also include,
where appropriate, the corresponding authority of a third
country;

(2) Council Directive 89/662/EEC of 11 December 1989 concerning
veterinary checks in intra-Community trade with a view to the
completion of the internal market (OJ L 395, 30.12.1989, p. 13).
Directive as last amended by Council Directive 92/118/EEC (OJ L
62, 15.3.1993, p. 49).

(3) Council Directive 90/425/EEC of 26 June 1990 concerning veteri-
nary and zootechnical checks applicable in intra-Community trade
in certain live animals and products with a view to the completion
of the internal market (OJ L 224, 18.8.1990, p. 29). Directive as
last amended by Council Directive 92/118/EEC.

L 147/4

EN

Official Journal of the European Communities

31.5.2001

(f) category: one of the classification categories referred to in

Chapter C of Annex II;

The specific definitions set out in Annex I shall also

2.
apply.

(g) specified risk material: the tissues specified in Annex V;
it does not include products

unless otherwise indicated,
containing or derived from those tissues;

(h) animal suspected of being infected by a TSE: live, slaugh-
tered or dead animals, which show or have shown neuro-
logical or behavioural disorders or a progressive deteriora-
tion of the general condition linked to impairment of the
central nervous system and for which the information
gathered on the basis of a clinical examination, response
to treatment, a post-mortem examination or an ante or
post-mortem laboratory analysis do not allow an alter-
native diagnosis to be established. Bovine spongiform
encephalopathies
shall be suspected in bovine
animals which have produced a positive result from a
rapid test specifically for BSE;

(BSE)

(i) holding: any place in which animals covered by this Regu-
lation are held, kept, bred, handled or shown to the public;

(j) sampling: the taking of samples, ensuring a statistically
correct representation, from animals or their environment,
or from products of animal origin, for the purpose of
establishing a disease diagnosis, familial relationships, for
health surveillance, or for the monitoring of the absence of
microbiological agents or of certain materials in products
of animal origin;

(k) fertilisers: any substance containing products of animal
origin utilised on land to enhance growth of vegetation; it
may include digestion residues from bio-gas production or
composting;

(l) rapid tests: the analysis methods referred to in Annex X,
Chapter C, point 4, and for which the results are known
within 24 hours;

(m) alternative test: the tests referred to in Article 8(2) which
are used as an alternative to the withdrawal of specified
risk material.

3. Where the terms in this Regulation are not defined in
paragraph 1 or Annex I,
the relevant definitions given in
Regulation (EC) No 1760/2000 (1) and those given in or
pursuant
to Directives 64/432/EEC (2), 89/662/EEC, 90/
425/EEC and 91/68/EEC (3) shall apply insofar as reference is
made to them in this text.

Article 4

Safeguard measures

1. With regard to the implementation of safeguard meas-
ures, the principles and provisions set out in Article 9 of
Directive 89/662/EEC, Article 10 of Directive 90/425/EEC,
Article 18 of Directive 91/496/EEC (4) and Article 22 of
Directive 97/78/EC (5) shall apply.

The safeguard measures shall be adopted in accordance
2.
with the procedure referred to in Article 24(2) and shall be
notified at the same time to the European Parliament, stating
the reasons.

CHAPTER II

DETERMINATION OF BSE STATUS

Article 5

Classification

1.
The BSE status of a Member State, of a third country, or
of one of their regions (hereinafter referred to as ‘countries or
regions’) may be determined only on the basis of the criteria set
out in Annex II, Chapter A, and the outcome of a risk analysis
on the basis of all the potential factors for the appearance of
bovine spongiform encephalopathy as defined in Annex II,
Chapter B, and their development over time.

Member States, and third countries wishing to be retained on
the list of third countries approved for the export to the
Community of the live animals or of the products covered by
this Regulation, shall submit to the Commission an application
for their BSE status to be determined, accompanied by the
relevant
in Annex II,
Chapter A, and on the potential risk factors specified in Annex
II, Chapter B, and their development over time.

information on the criteria set out

(1) Regulation (EC) No 1760/2000 of the European Parliament and of
the Council of 17 July 2000 establishing a system for the identifica-
tion and registration of bovine animals and regarding the labelling
of beef and beef products and repealing Council Regulation (EC) No
820/97 (OJ L 204, 11.8.2000, p. 1).

(2) Council Directive 64/432/EEC of 26 June 1964 on animal health
problems affecting intra-Community trade in bovine animals and
swine (OJ 121 29.7.1964, p. 1977/64). Directive as last amended
by Directive 2000/20/EC of
the
Council (OJ L 163, 4.7.2000, p. 35).

the European Parliament and of

(3) Council Directive 91/68/EEC of 28 January 1991 on animal health
conditions governing intra-Community trade in ovine and caprine
animals (OJ L 46, 19.2.1991, p. 19). Directive as last amended by
Commission Decision 94/953/EC (OJ L 371, 31.12.1994, p. 14).
(4) Council Directive 91/496/EEC of 15 July 1991 laying down the
principles governing the organisation of veterinary checks on
animals entering the Community from third countries and amending
Directives 89/662/EEC, 90/425/EEC and 90/675/EEC (OJ L 268,
24.9.1991, p. 56). Directive as last amended by Directive 96/43/EC
(OJ L 162, 1.7.1996, p. 1).

(5) Council Directive 97/78/EC of 18 December 1997 laying down the
principles governing the organisation of veterinary checks on
products entering the Community from third countries (OJ L 24,
30.1.1998, p. 9).

31.5.2001

EN

Official Journal of the European Communities

L 147/5

A decision on each application, placing the Member State
2.
or third country or region of
the Member State or third
country which submitted the application in one of the catego-
ries defined in Annex II, Chapter C, shall be adopted, taking
account of the criteria and potential risk factors set out in
paragraph 1, in accordance with the procedure referred to in
Article 24(2).

This decision shall be taken within six months of the submis-
sion of the application and of the relevant information referred
to in the second subparagraph of paragraph 1. If the Commis-
sion finds that the supporting evidence does not include the
information laid down in Annex II, Chapters A and B, it shall
ask for additional information to be provided within a period
to be specified. The final decision shall then be taken within six
months of the submission of all

information.

After the International Office of Epizootic Diseases (OIE) has
established a procedure for the classification of countries by
category and if it has placed the applicant country in one of
those categories, a re-assessment of the Community categorisa-
tion of the country concerned in accordance with the first
subparagraph of this paragraph may be decided, if appropriate,
in accordance with the procedure referred to in Article 24(2).

3.
If the Commission finds that the information submitted
by a Member State or a third country pursuant to Annex II,
Chapters A and B, is insufficient or unclear, it may, in accord-
ance with the procedure referred to in Article 24(2), determine
the BSE status of the Member State or third country concerned
on the basis of a full risk analysis.

to in Annex II, Chapter C, until they have submitted such an
application.

5. Member States shall notify the Commission as soon as
possible of any epidemiological evidence or other information
which might lead to a change in BSE status, in particular the
results of
in
Article 6.

the monitoring programmes provided for

6.
The retention of a third country on one of the lists
provided for by Community rules for the purpose of being
allowed to export to the Community live animals and products
of animal origin for which this Regulation provides specific
rules shall be decided upon under the procedure laid down in
Article 24(2) and shall be made conditional — in the light of
the information available or where a TSE is presumed to be
present — on the information provided for in paragraph 1
being supplied.
In the event of refusal to supply the said
information within three months of the date of the Commis-
sion's request, the provisions of paragraph 4 of this Article
shall apply until
this information has been submitted and
evaluated in accordance with paragraphs 2 or 3.

The eligibility of third countries to export to the Community
live animals, or products of animal origin for which this Regu-
lation provides specific rules, under conditions based on their
category as established by the Commission, shall be conditional
upon their undertaking to notify the latter in writing as soon as
possible of any epidemiological or other evidence which might
lead to a change in BSE status.

A decision may be taken, under the procedure laid down
7.
in Article 24(2), to change the BSE classification of a Member
State or third country, or of one of its regions, in accordance
with the results of the checks provided for in Article 21.

Such a risk analysis must include a conclusive statistical survey
of the epidemiological situation regarding TSEs in the applicant
Member State or third country, on the basis of the use, in a
screening procedure, of rapid tests. The Commission shall take
into account the classification criteria used by the OIE.

8.
The decisions referred to in paragraphs 2, 3, 4, 6 and 7
shall be based on a risk assessment, taking into consideration
the recommended criteria set out in Annex II, Chapters A
and B.

The rapid tests shall be approved for that purpose in accord-
ance with the procedure referred to in Article 24(2) and
entered on a list set out in Annex X, Chapter C, point 4.

Such screening procedure may also be used by Member States
or third countries which wish to have the classification they
carried out on that basis approved by the Commission — in
accordance with the procedure laid down in Article 24(2).

CHAPTER III

PREVENTION OF TSE

Article 6

Monitoring system

The cost of such screening procedure shall be borne by the
Member State or third country concerned.

4. Member States or
third countries which have not
submitted an application in accordance with paragraph 1
within six months of 1 July 2001 shall, with respect to the
dispatch from their territory of live animals and products of
animal origin, be considered as countries in category 5, referred

1.
Each Member State shall carry out an annual programme
for monitoring BSE and scrapie in accordance with Annex III,
Chapter A. That programme shall include a screening proce-
dure using rapid tests.

Rapid tests shall be approved for that purpose in accordance
with the procedure referred to in Article 24(2) and listed in
Annex X, Chapter C, point 4.

L 147/6

EN

Official Journal of the European Communities

31.5.2001

Each Member State shall inform the Commission and the
Standing Veterinary

2.
other Member
States, within the
Committee, of the emergence of a TSE other than BSE.

All official

3.
investigations and laboratory examinations
shall be recorded in accordance with Annex III, Chapter B.

Paragraph 1 shall not apply to tissues from animals
2.
which have undergone an alternative test approved for that
distinct purpose in accordance with the procedure referred to
in Article 24(2) and listed in Annex X, Chapter C, point 5, and
applied under the conditions listed in point 5 of Annex V —
and where the results of the test were negative.

4. Member States shall submit an annual report
to the
Commission covering at least the information referred to in
Annex III, Chapter B, Part I. The report for each calendar year
shall be submitted at the latest by 31 March of the following
year. The Commission shall present a summary of the national
reports covering at least the information referred to in Annex
III, Chapter B, Part II, to the Standing Veterinary Committee
within three months of the receipt of the said reports.

Article 7

Prohibitions concerning animal feeding

The feeding to ruminants of protein derived from

1.
mammals is prohibited.

2.
Furthermore, the prohibition referred to in paragraph 1
shall be extended to animals and products of animal origin in
accordance with point 1 of Annex IV.

Paragraphs 1 and 2 shall apply without prejudice to the

3.
provisions set out in point 2 of Annex IV.

4. Member States, or regions thereof, in category 5 shall not
be permitted to export or store feed intended for farmed
animals which contains protein derived from mammals or feed
intended for mammals, except
for dogs and cats, which
contains processed protein derived from mammals.

Third countries, or regions thereof, in category 5 shall not be
permitted to export to the Community feed intended for live-
stock which contains protein derived from mammals or feed
for dogs and cats, which
intended for mammals, except
contains processed protein derived from mammals.

5.
Detailed rules for the implementation of this Article, in
particular rules on the prevention of cross-contamination and
on the methods of sampling and analysis required to check
compliance with this Article, shall be adopted in accordance
with the procedure referred to in Article 24(2).

Article 8

Specified risk material

The

1.
removed and
destroyed in accordance with points 2, 3, 4 and 8 of Annex V.

specified risk material

shall be

That specified risk material or the material processed therefrom
may be placed on the market or, if need be, exported only for
final destruction in accordance with points 3 and 4 or as
appropriate 7(c) or 8 of Annex V. It may not be imported into
the Community. Transit of specified risk material
through
Community territory must take place in accordance with the
requirements of Article 3 of Directive 91/496/EEC.

The Member States which authorise that alternative test must
inform the other Member States and the Commission.

3.
In Member States, or regions thereof, which are placed in
categories 2, 3, 4 and 5 referred to in Annex II, Chapter C, the
laceration, after stunning, of central nervous tissue by means of
an elongated rod-shaped instrument introduced into the cranial
cavity shall not be used on bovine, ovine or caprine animals
whose meat is destined for human or animal consumption.

The data relating to age set out in Annex V shall be
4.
adjusted regularly. Such adjustments shall be based on the
latest proven scientific findings concerning the statistical prob-
ability of the occurrence of a TSE in the relevant age groups of
the Community's bovine, ovine and caprine population.

5.
By way of derogation from paragraphs 1 to 4, a decision
may be adopted, in accordance with the procedure referred to
in Article 24(2), with regard to the date of effective enforce-
ment of Article 7(1) or, as appropriate, in the third countries,
the date of banning the use of mammalian protein in feed for
ruminants in each country or region placed in category 3 or 4,
in order to limit the application of this Article to animals born
before that date in those countries or regions.

Similarly, by way of derogation from paragraphs 1 to 4, after
consultation of the appropriate scientific committee and on the
basis of an assessment of the incident, propagation and human
exposure risk, a decision may be adopted in accordance with
the procedure referred to in Article 24(2) to allow the use for
food, feed and fertilisers of vertebral column and dorsal root
ganglia from bovine animals in or coming from each country
or region thereof placed in category 5.

6.
Rules for the implementation of this Article shall be
adopted in accordance with the procedure referred to in
Article 24(2).

Article 9

Products of animal origin derived from or containing
ruminant material

1.
The products of animal origin listed in Annex VI shall
not be produced from ruminant material from countries or
regions thereof which are placed in category 5 unless they are
produced in accordance with the production processes
approved in accordance with the procedure referred to in
Article 24(2).

2.
Bones of the head, and vertebral columns of bovine,
ovine and caprine animals from countries, or regions thereof,
which are placed in categories 2, 3, 4 or 5, shall not be used
for the production of mechanically recovered meat.

31.5.2001

EN

Official Journal of the European Communities

L 147/7

Paragraphs 1 and 2 shall not apply, in the light of the
3.
criteria set out in point 5 of Annex V, to ruminants which have
undergone an alternative test which has been recognised in
accordance with the procedure referred to in Article 24(2),
where the results of the test were negative.

4.
Rules for the implementation of this Article shall be
adopted in accordance with the procedure referred to in
Article 24(2).

Article 10

Education programmes

1. Member States shall ensure that staff of the competent
authority, of diagnostic laboratories and colleges of agriculture
and veterinary medicine, official veterinarians, veterinary practi-
tioners, slaughterhouse personnel and animal breeders, keepers
and handlers have been given training in the clinical signs,
epidemiology and, in the case of staff responsible for carrying
out checks, in interpreting laboratory findings relating to TSEs.

To ensure effective implementation of

2.
the education
programmes provided for in paragraph 1, financial assistance
from the Community may be granted. The amount of such
assistance shall be determined in accordance with the proce-
dure referred to in Article 24(2).

CHAPTER IV

CONTROL AND ERADICATION OF TSEs

Article 11

Notification

Without prejudice to Directive 82/894/EEC (1), the Member
States shall ensure that any animal suspected of being infected
by a TSE is notified immediately to the competent authorities.

Member States shall regularly inform each other and the
Commission of the cases of TSE notified.

The competent authority shall without delay take the measures
laid down in Article 12 of this Regulation, together with any
other necessary measures.

Article 12

Measures with respect to suspect animals

1.
Any animal suspected of being infected by a TSE shall be
placed under an official movement restriction until the results
of a clinical and epidemiological examination carried out by

the competent authority are known, or killed for laboratory
examination under official control.

If BSE is suspected in a bovine animal at a holding in a
Member State, all other bovine animals from that holding shall
be placed under an official movement restriction until the
results of the examination are available.

If BSE is suspected in an ovine or caprine animal at a holding
in a Member State on the basis of objective evidence such as
the results of tests capable of differentiating in a practical way
between the various TSEs, all other ovine and caprine animals
from that holding shall be placed under an official movement
restriction until the results of the examination are available.

If there is evidence that the holding where the animal was
present when BSE was suspected is not likely to be the holding
the
where the animal could have been exposed to BSE,
competent authority may decide that only the animal suspected
of being infected shall be placed under an official movement
restriction. If considered necessary, the competent authority
may also decide that other holdings or only the holding of
exposure shall be placed under official control depending on
information available.
the epidemiological

Under the procedure referred to in Article 24(2) and by way of
derogation from the requirements of the second, third and
fourth subparagraphs of this paragraph, a Member State may
be exempted from the application of official restrictions on the
movement of animals if it applies measures offering equivalent
safeguards.

2. Where the competent authority decides that the poss-
ibility of infection with a TSE cannot be ruled out, the animal
shall be killed, if it is still alive; its brain and all other tissues as
the competent authority may determine shall be removed and
sent to an officially approved laboratory, the national reference
laboratory provided for in Article 19(1) or the Community
reference laboratory provided for in Article 19(2), for exam-
ination in accordance with the testing methods laid down in
Article 20.

3.
All parts of the body of the suspect animal including the
hide shall be retained under official control until a negative
diagnosis has been made or shall be destroyed in accordance
with Annex V, point 3 or 4.

Rules for the implementation of this Article shall be
4.
adopted in accordance with the procedure referred to in
Article 24(2).

Article 13

Measures following confirmation of the presence of a TSE

(1) Council Directive 82/894/EEC of 21 December 1982 on the notifi-
cation of animal diseases within the Community (OJ L 378,
31.12.1982, p. 58). Directive as last amended by Commission Deci-
sion 2000/556/EC (OJ L 235, 19.9.2000, p. 27).

1. When the presence of a TSE has been officially
confirmed, the following measures shall be applied as soon as
possible:

L 147/8

EN

Official Journal of the European Communities

31.5.2001

(a) all parts of the body of the animal shall be completely
destroyed in accordance with Annex V apart from material
retained for
in accordance with Annex III,
Chapter B, III, 2;

records

Rules for the implementation of this Article shall be
6.
adopted in accordance with the procedure referred to in
Article 24(2).

(b) an inquiry shall be carried out to identify all animals at risk

in accordance with Annex VII, point 1;

(c) all animals and products of animal origin referred to in
Annex VII, point 2, that have been identified as being at
risk by the inquiry referred to in (b), shall be killed and
completely destroyed in accordance with Annex V, points 3
and 4.

By way of derogation from this paragraph, Member States may
apply other measures offering an equivalent level of protection,
if those measures have been approved in accordance with the
procedure referred to in Article 24(2).

2.
Pending the implementation of the measures referred to
in paragraph 1(b) and (c), the holding on which the animal was
present when the presence of a TSE was confirmed shall be
placed under official control and all movement of animals
susceptible to TSEs and products of animal origin derived from
them from or to the holding shall be subject to authorisation
by the competent authority, with a view to ensuring immediate
the animals and products of
tracing and identification of
animal origin concerned.

If there is evidence that the holding where the affected animal
was present when the TSE was confirmed is not likely to be the
holding where the animal was exposed to the TSE,
the
competent authority may decide that both holdings or only the
holding of exposure shall be placed under official control.

Article 14

Contingency plan

1. Member States shall draw up — in accordance with the
general criteria of Community rules on the control of animal
diseases — guidelines specifying the national measures to be
implemented and indicating competences and responsibilities
where cases of TSE are confirmed.

2. Where necessary to enable Community legislation to be
the guidelines may be harmonised in
applied uniformly,
accordance with the procedure referred to in Article 24(2).

CHAPTER V

PLACING ON THE MARKET AND EXPORT

Article 15

Live animals, their semen, embryos and ova

1.
Placing on the market or, if need be, export of bovine,
ovine or caprine animals and their semen, embryos and ova
shall be subject to the conditions laid down in Annex VIII, or,
in the case of imports, to the conditions laid down in Annex
IX. The live animals and their embryos and ova shall be accom-
panied by the appropriate animal health certificates as required
by Community legislation, in accordance with Article 17 or, in
the case of imports, Article 18.

3. Member States which have implemented a substitute
scheme offering equivalent safeguards provided for in the fifth
subparagraph of Article 12(1) may, by way of derogation from
the requirements of paragraph 1(b) and (c), be exempted in
accordance with the procedure referred to in Article 24(2) from
the requirement to apply official restrictions on the movement
to kill and destroy
of animals and from the requirement
animals.

2.
The placing on the market of first generation progeny,
semen, embryos and ova of TSE suspect or confirmed animals
shall be subject to the conditions laid down in Annex VIII,
Chapter B.

3.
Rules for the implementation of this Article shall be
adopted in accordance with the procedure referred to in
Article 24(2).

4.
Owners shall be compensated without delay for the loss
of the animals that have been killed or products of animal
origin destroyed in accordance with Article 12(2) and para-
graph 1(a) and (c) of this Article.

5. Without
the
confirmed presence of any TSE other than BSE shall be notified
to the Commission on an annual basis.

to Directive

82/894/EEC,

prejudice

Article 16

Placing on the market of products of animal origin

The following products of animal origin derived from
1.
healthy ruminants shall not be subject
to restrictions on
placing on the market or, if need be, export pursuant to this
Article, to Annex VIII, Chapters C and D, and to Annex IX,
Chapters A, C, F and G:

31.5.2001

EN

Official Journal of the European Communities

L 147/9

(a) products of animal origin covered by Article 15, in partic-

ular semen, embryos and ova;

(b)

(i) raw milk within the meaning of Directive 92/

46/EEC (1);

apply to products of animal origin listed in Annex VIII,
Chapter C, and fulfilling the requirements of Annex VIII,
Chapter C. They must be accompanied by an animal health
certificate issued by an official veterinarian certifying that they
have been produced in conformity with this Regulation.

(ii) milk for

the manufacture of milk-based products

within the meaning of Directive 92/46/EEC;

(iii) heat-treated drinking milk within the meaning of

Directive 92/46/EEC;

(iv) di-calcium phosphate (without any trace of protein or

fat);

(v) hides and skins within the meaning of Directive 92/

118/EEC (2);

(vi) gelatine within the meaning of Directive 92/118/EEC,
derived from the hides and skins referred to in
point (v);

(vii) collagen derived from the hides and skins referred to

in point (v).

2.
Products of animal origin imported from a third country
placed in categories 2, 3, 4 and 5 must come from healthy
bovine, ovine and caprine animals which have not been
subjected to a laceration of
the central nervous tissue as
referred to in Article 8(3) or killed by means of a gas injected
into the cranial cavity.

4. When an animal is moved from a country or a region to
it shall be
country or region included in another category,
classified in the highest category of the countries or regions in
which it has stayed over twenty-four hours unless adequate
guarantees can be provided certifying that the animal has not
received feedingstuffs from the country or region classified in
the highest category.

Products of animal origin for which this Article lays
5.
down specific rules shall be accompanied by the appropriate
animal health certificates or commercial documents as required
by Community legislation in accordance with Articles 17 and
18 or, if such certificates or documents are not provided for in
Community legislation, by a health certificate or commercial
document
the specimens of which shall be established in
accordance with the procedure referred to in Article 24(2).

6.
For the purpose of import into the Community, products
of animal origin shall comply with the conditions laid down in
Annex IX, Chapters A, C, F and G.

3.
Products of animal origin containing materials obtained
from bovine animals originating in a Member State, a region of
a Member State or a third country classified in category 5 shall
not be placed on the market unless they come from:

7.
In accordance with the procedure referred to in Article
24(2), the provisions of paragraphs 1 to 6 may be extended to
other products of animal origin. Rules for the implementation
of this Article shall be adopted by the same procedure.

(a) animals born after the date from which the prohibition on
the feeding to ruminants of animal protein derived from
mammals was effectively enforced; or

(b) animals which were born, raised and have stayed in herds
with a certified history of freedom from BSE for at least
seven years.

Article 17

Furthermore, products of animal origin shall not be despatched
from a Member State or a region of a Member State classified
in category 5 to another Member State or be imported from a
third country classified in category 5. That prohibition shall not

(1) Council Directive 92/46/EEC of 16 June 1992 laying down the
health rules for the production and placing on the market of raw
milk, heat-treated milk and milk-based products
(OJ L 268,
14.9.1992, p. 1). Directive as last amended by Directive 96/23/EC
(OJ L 23.5.1996, p. 10).

(2) Council Directive 92/118/EEC of 17 December 1992 laying down
animal health and public health requirements governing trade in
and imports into the Community of products not subject to the
said requirements laid down in specific Community rules referred to
in Annex A(1) to Directive 89/662/EEC and, as regards pathogens,
in Directive 90/425/EEC (OJ L 62, 15.3.1993, p. 49). Directive as
last amended by Commission Decision 1999/724/EC (OJ L 290,
12.11.1999, p. 32).

Under the procedure referred to in Article 24(2), the health
certificates referred to in Annex F to Directive 64/432/EEC,
Models II and III in Annex E to Directive 91/68/EEC and the
appropriate health certificates laid down by Community legisla-
tion relating to trade in the semen, embryos and ova of bovine,
ovine or caprine animals shall be supplemented, where neces-
sary, by a reference to the category specifying the classification
of the Member State or region of origin given in accordance
with Article 5.

Appropriate commercial documents relating to trade in prod-
ucts of animal origin shall be supplemented, where necessary,
by a reference to the category of the Member State or region of
origin given by the Commission in accordance with Article 5.

L 147/10

EN

Official Journal of the European Communities

31.5.2001

Article 18

CHAPTER VII

The appropriate health certificates relating to imports provided
for by Community legislation shall, under
the procedure
referred to in Article 24(2), be supplemented in respect of third
countries classified in a category pursuant to Article 5 by the
specific requirements laid down in Annex IX, as soon as that
classification decision has been taken.

CHAPTER VI

REFERENCE LABORATORIES, SAMPLING, TESTING AND
CONTROLS

Article 19

Reference laboratories

1.
The national reference laboratories in each Member State
and their functions and duties shall be those indicated in
Annex X, Chapter A.

2.
The Community reference laboratory and its functions
and duties shall be those laid down in Annex X, Chapter B.

TRANSITIONAL AND FINAL PROVISIONS

Article 22

Transitional measures concerning specified risk material

The provisions of Annex XI, Part A shall apply for a
1.
period of at least six months from 1 July 2001 and shall cease
to apply immediately following the date of adoption of a
decision in accordance with Article 5(2) or (4), on which date
Article 8 shall enter into force.

2.
The results of a conclusive statistical survey carried out in
accordance with Article 5(3) during the transitional period shall
be used to confirm or overturn the risk analysis conclusions
referred to in Article 5(1), while taking account of the classi-
fication criteria defined by the OIE.

After

consultation

3.
scientific
committee, detailed rules concerning that statistical survey shall
be adopted in accordance with the procedure referred to in
Article 24(2).

appropriate

the

of

The minimum criteria to be met by this statistical survey

4.
shall be those laid down in Part B of Annex XI.

Article 20

Article 23

Sampling and laboratory methods

Amendment of the annexes and transitional measures

1.
Sampling and laboratory testing for the presence of a TSE
shall be carried out using the methods and protocols laid down
in Annex X, Chapter C.

2. Where necessary to ensure the uniform application of
this Article,
including the method to
confirm BSE in ovine and caprine animals, shall be adopted in
accordance with the procedure referred to in Article 24(2).

implementing rules,

After consultation of the appropriate scientific committee on
any question which could have an impact on public health, the
annexes shall be amended or supplemented and any appro-
priate transitional measures shall be adopted in accordance
with the procedure referred to in Article 24(2).

In accordance with that procedure, transitional measures shall
be adopted for a maximum period of two years to permit the
change-over from the current arrangements to the arrange-
ments established by this Regulation.

Article 21

Community controls

1.
Experts from the Commission may make on-the-spot
checks in cooperation with the competent authorities of the
Member States, insofar as is necessary for the uniform applica-
tion of this Regulation. The Member State in whose territory
checks are made shall provide the experts with all the assis-
tance necessary for carrying out their duties. The Commission
shall
inform the competent authority of the results of the
checks made.

The rules for the application of this Article, and in particular
those governing the procedure for cooperation with the
national authorities, shall be adopted in accordance with the
procedure referred to in Article 24(2).

2.
Community checks concerning third countries shall be
made in accordance with Articles 20 and 21 of Directive
97/78/EC.

Article 24

Committees

1.
The Commission shall be assisted by the Standing Veter-
inary Committee. However, for matters exclusively concerning
animal feedingstuffs, the Commission shall be assisted by the
Standing Committee on Feedingstuffs and, for matters exclu-
sively concerning foodstuffs, by the Standing Committee on
Foodstuffs.

2. Where reference is made to this paragraph, Articles 5 and
7 of Decision 1999/468/EC shall apply, in compliance with
Article 8 thereof.

The period referred to in Article 5(6) of that Decision shall be
three months and, in the case of safeguard measures referred to
in Article 4(2) of this Regulation, 15 days.

3.

Each Committee shall adopt its rules of procedure.

31.5.2001

EN

Official Journal of the European Communities

L 147/11

Article 25

Consultation of the scientific committees

The appropriate scientific committees shall be consulted on any matter within the scope of this Regulation
which could have an impact on public health.

Article 26

Entry into force

This Regulation shall enter into force on the day following its publication in the Official Journal of the
European Communities.

It shall apply from 1 July 2001.

This Regulation shall be binding in its entirety and directly applicable in all Member States.

Done at Brussels, 22 May 2001.

For the European Parliament

The President

N. FONTAINE

For the Council

The President

M. WINBERG

L 147/12

EN

Official Journal of the European Communities

31.5.2001

ANNEX I

SPECIFIC DEFINITIONS

For the purpose of this Regulation:

(a) ‘indigenous case of BSE’ means a case of bovine spongiform encephalitis which has not been clearly demonstrated to

be due to infection prior to importation as a live animal, embryo or ovum;

(b) ‘discrete adipose tissue’ means internal and external body fat removed during the slaughter and cutting process, in
particular fresh fat from the heart, caul, kidneys and mesentery of bovine animals, and fat from cutting rooms;

(c) ‘cohort’ means a group of bovine animals which were either born in the same herd as, and within 12 months
preceding or following the birth of, the affected cattle or reared together with the affected animal at any time during
the first year of their life and which may have consumed the same feed as that which the affected animal consumed
during the first year of its life;

(d) ‘landfill site’ means a waste disposal site as defined by Directive 1999/31/EC (1).

(1) Council Directive 1999/31/EC of 26 April 1999 on the landfill of waste (OJ L 182, 16.7.1999, p. 1).

31.5.2001

EN

Official Journal of the European Communities

L 147/13

ANNEX II

DETERMINATION OF BSE STATUS

CHAPTER A

The BSE status of a Member State or a third country or of one of their regions, hereinafter referred to as ‘country or
region’, shall be determined on the basis of the following criteria:

(a) the outcome of a risk analysis identifying all the potential factors for the appearance of BSE referred to in Chapter B

and their development over time;

(b) an education programme for veterinarians, breeders and those who transport, trade in and slaughter bovine animals,
which seeks to encourage them to report all cases of neurological manifestations in adult bovine animals;

(c) the compulsory reporting and examination of all bovine animals showing clinical signs of BSE;

(d) a system of continuous surveillance and monitoring of BSE with particular reference to the risks described in Chapter
B, taking account of the guidelines in the table of Chapter A of Annex III or in accordance with the appropriate
international standards; reports on the number of examinations carried out and the results thereof must be kept for at
least seven years;

(e) the examination in an approved laboratory of samples of encephala or other tissues collected under the surveillance

system mentioned in point (d).

CHAPTER B

The risk analysis referred to in Chapter A(a) shall be based on the following factors:

— the consumption by bovine animals of meat and bone meal or greaves derived from ruminants;
— the importation of meat and bone meal or greaves potentially contaminated by a TSE or animal feed containing meat

and bone meal or greaves;

— the importation of animals or ova/embryos potentially infected by a TSE;
— the epidemiological status of the country or region in regard to animal TSEs;
— the extent of knowledge about the structure of the bovine, ovine and caprine population in the country or region;
— the source of animal waste, the parameters of the processes for treating such waste and the methods of producing

animal feed.

CHAPTER C

Definition of categories

The BSE status of Member States or third countries or one of the regions thereof shall be determined by classification into
the following categories:

A. CATEGORY 1: Country or region free of BSE

A country or region where a risk analysis based on the information laid down in Chapter B has been conducted which
demonstrated that appropriate measures have been taken for the relevant period of time, to manage any risk identified
and

1. EITHER no BSE case has been recorded and:

(i) the criteria in Chapter A(b) to (e) have been complied with for at least seven years, or
(ii) the criteria in Chapter A(c) have been complied with for at least seven years and it has been demonstrated that
for at least eight years no meat and bone meal or greaves derived from ruminants or mammals has been fed to
ruminants;

2. OR where all cases of BSE have been clearly demonstrated to originate directly from the importation of live bovine
animals or bovine embryos/ova, and all the affected bovine animals as well as, if these are females, their last
progeny born within two years prior to, or after, the first clinical signs of onset of the disease, if alive in the
country or region, have been killed and completely destroyed and, either

(i) the criteria in Chapter A(b) to (e) have been complied with for at least seven years, or
(ii) the criteria in Chapter A(c) have been complied with for at least seven years and it has been demonstrated that

for at least eight years no meat and bone meal or greaves have been fed to ruminants;

3. OR where the last indigenous case of BSE was reported more than seven years ago, the criteria in Chapter A(b) to
(e) have been complied with for at least seven years and the feeding of ruminants with meat and bone meal and
greaves derived from ruminants has been banned and the ban has been effectively enforced for at least eight years.

L 147/14

EN

Official Journal of the European Communities

31.5.2001

B. CATEGORY 2: BSE provisionally free country or region where no indigenous case has been reported

Country or region where a risk analysis as described in Chapter B has been conducted which demonstrates that
appropriate measures have been taken for the relevant period of time to manage any risk identified, and

1. EITHER where there has been no case of BSE and:

(i) the criteria in Chapter A(b) to (e) are complied with, but have not been complied with for seven years, or
(ii) it has been demonstrated that for at least eight years no meat and bone meal or greaves has been fed to

ruminants, but the criteria in Chapter A(c) have not been complied with for seven years;

2. OR where all cases of BSE have been clearly demonstrated to originate directly from the importation of live bovine
animals or bovine embryos/ova, and all the affected bovine animals as well as, if these are females, their last
progeny born within two years prior to, or after, the first clinical signs of onset of the disease, if alive in the
country or region, have been killed and completely destroyed, and either:

(i) the criteria in Chapter A(b) to (e) are complied with, but have not been complied with for seven years, or
(ii) it has been demonstrated that for at least eight years no meat and bone meal or greaves has been fed to

ruminants, but the criteria in Chapter A(c) have not been complied with for seven years.

C. CATEGORY 3: BSE provisionally free country or region where at least one indigenous case has been reported

Any country or region where a risk analysis based on the information referred to in Chapter B has been conducted
which demonstrates that appropriate measures have been taken for the relevant period of time to manage any risk
identified and:

1. EITHER the last indigenous case of BSE was reported more than seven years ago, the criteria in Chapter A(b) to (e)
are complied with and the ban on feeding ruminants with meat and bone meal and greaves derived from ruminants
is effectively enforced, but:

(i) the criteria in Chapter A(b) to (e) have not been complied with for seven years, or
(ii) the ban on feeding ruminants with meat and bone meal and greaves derived from ruminants has not been

effectively enforced for eight years;

2. OR where the last indigenous case has been reported less than seven years ago, the BSE incidence rate, calculated
on the basis of indigenous cases, has been less than one case per million during each of the last four consecutive
twelve-month periods within the bovine animal population over 24 months of age in the country or region or —
when in a country or a region the bovine animal population over 24 months of age is less than 1 million animals
— one case per real number of this population (calculated on the basis of Eurostat statistics), and where:

(i) the ban on feeding ruminants with meat and bone meal and greaves derived from ruminants has been

effectively enforced for at least eight years;

(ii) the criteria in Chapter A(b) to (e) have been complied with for at least seven years;
(iii) the affected bovine animals as well as:

— if these are females, their last progeny born within two years prior to, or after, clinical onset of the disease;
— all bovine animals from the cohort,

are killed and completely destroyed if they are still alive in the country or region concerned.

For this classification account may be taken, by way of derogation from point (iii), of the existence of other
measures offering an equivalent level of protection in relation to the killing of animals at risk.

D. CATEGORY 4: Country or region with low incidence of BSE

Any country or region where:

1. the criteria listed in Chapter A are complied with, and the BSE incidence rate, calculated over the past 12 months,
has been greater than or equal to one indigenous case per million and less than or equal to one hundred cases per
million within the bovine animal population over 24 months of age in the country or region; or

2. the criteria listed in Chapter A are complied with and the BSE incidence rate, calculated as specified in point 1 has
been less than one indigenous case per million for less than four consecutive 12 month periods and the affected
cattle as well as:

— if these are females, their last progeny born within two years prior to, or after the first clinical signs of onset of

the disease,

— all bovine animals from the cohort,

if alive in the country or region, are killed and completely destroyed.

For this classification account may be taken, by way of derogation from this point, of the existence of other
measures offering an equivalent level of protection in relation to the killing of animals at risk.

Countries or regions where the BSE incidence rate, calculated over the past 12 months, has been less than one
indigenous case per million within the cattle population over 24 months of age in the country or region, but
where a risk analysis as described in Chapter A has been conducted which demonstrates that at least one of the
criteria enabling the country or region to be classified in category 2 or 3 is not complied with, must be regarded as
countries or regions belonging to category 4.

31.5.2001

EN

Official Journal of the European Communities

L 147/15

E. CATEGORY 5: Country or region with high incidence of BSE

Any country or region where:

1. the criteria listed in Chapter A are complied with, and the BSE incidence rate, calculated over the past 12 months,
has been greater than one hundred cases per million within the bovine animal population over 24 months of age
in the country or region; or

2. the BSE incidence rate, calculated over the past 12 months, has been greater than or equal to one case per million
and less than or equal to one hundred cases per million within the bovine animal population over 24 months of
age in the country or region, and at least one of the criteria listed in Chapter A is not complied with.

L 147/16

EN

Official Journal of the European Communities

31.5.2001

ANNEX III

MONITORING SYSTEM

CHAPTER A

I. MINIMUM REQUIREMENTS FOR A PROGRAMME FOR MONITORING BSE IN BOVINE ANIMALS

1.

Selection of sub-populations

Bovine animals over 30 months of age as follows:

1.1 Animals subject to ‘special emergency slaughtering’ as defined in Article 2(n) of Directive 64/433/EEC (1) and
animals slaughtered in accordance with Annex I, Chapter VI, point 28(c), of Directive 64/433/EEC (including
animals referred to in Regulation (EC) No 716/96 (2), and subject to ‘special emergency slaughtering’ as referred
to above or slaughtered in accordance with Annex I, Chapter VI, point 28(c), of Directive 64/433/EEC).

1.2 Dead animals not slaughtered for human consumption, having died on the farm or during transport (excluding

animals referred to in Commission Regulation (EC) No 716/96).

1.3 Animals slaughtered normally for human consumption.

1.4 Animals displaying a neurological disorder.

2.

Sample size

2.1. The number of samples tested annually in each Member State from the sub-population referred to in point 1.1

must include all animals in that sub-population.

2.2. The number of samples tested annually in each Member State from the sub-populations referred to in point 1.2
must not be less than the sample sizes indicated in the table. The selection of samples shall be random. The
sampling must be representative for each region and continuous.

2.3. The number of samples tested annually in each Member State from the sub-population referred to in point 1.3

must include all animals in that sub-population.

Total population over 30 months (1)

Sample size (2)

100 000

200 000

300 000

400 000

500 000

600 000

700 000

800 000

900 000

1 000 000

1 500 000

2 000 000

2 500 000

3 000 000

950

1 550

1 890

2 110

2 250

2 360

2 440

2 500

2 550

2 590

3 000

3 500

4 000

4 500

(1) Council Directive 64/433/EEC of 26 June 1964 on health problems affecting intra-Community trade in fresh meat

(OJ 121,

29.7.1964, p. 2012/64). Directive as last amended by Directive 95/23/EC (OJ L 243, 11.10. 1993, p. 7).

(2) Commission Regulation (EC) No 716/96 of 19 April 1996 adopting exceptional support measures for the beef market in the
United Kingdom (OJ L 99, 20.4.1996, p. 14). Regulation as last amended by Regulation (EC) No 1176/2000 of the Commission
(OJ L 131, 1.6.2000, p. 37).

31.5.2001

EN

Official Journal of the European Communities

L 147/17

Total population over 30 months (1)

Sample size (2)

3 500 000

4 000 000

4 500 000

5 000 000

5 500 000

6 000 000

6 500 000

7 000 000

7 500 000

8 000 000

8 500 000

9 000 000

9 500 000

10 000 000

10 500 000

11 000 000

11 500 000

12 000 000

5 000

5 500

6 000

6 500

7 000

7 500

8 000

8 500

9 000

9 500

10 000

10 500

11 000

11 500

12 000

12 500

13 000

13 500

(1) Where the size of the total population over 30 months is unknown, the size of the population over 24 months should be

taken as a basis.

(2) The sample size has been calculated to detect a prevalence of 0,1 % with 95 % reliability in the sub-populations referred to in
point 1, based on the assumption that the proportion of these sub-populations in the total population of bovine animals over
30 months of age is 1 %. Where the size of the total population of bovine animals over 30 months of age is 1 500 000
animals or more, the sample size has been increased by 500 samples per 500 000 animals as a proportionality adjustment, to
take account of the larger likelihood of variation in risk of BSE within the population.

II. MINIMUM REQUIREMENTS FOR A PROGRAMME FOR MONITORING SCRAPIE IN OVINE AND CAPRINE

ANIMALS

1. Selection of sub-populations

Selection must be by means of a risk assessment of sub-populations of native-born animals displaying clinical signs
compatible with scrapie. Within each sub-population and age group, selection must be random.

The following shall be the criteria for the selection:

— animals displaying a neurological or behavioural disorder lasting for at least 15 days and resistant to treatment;
— moribund animals without signs of infectious or traumatic illness;
— animals displaying other progressive disease conditions.

Ovine and caprine animals must be examined for scrapie and, when tests that can differentiate in practice between
TSEs are available, for BSE.

2. Age of targeted animals

The sample must target the oldest animals in the sub-population. However, all targeted animals must be over 12
months of age.

3. Sample size

The minimum number of animals to be examined on an annual basis must comply with the sample sizes referred
to in the table. Animals examined in accordance with Article 12 may be included within the minimum sample size.

L 147/18

EN

Official Journal of the European Communities

31.5.2001

Minimum number of annual neurohistological

investigations of animals showing signs compatible

with TSE

Table

Total population over
12 months (*)

Sample size

100 000

300 000

500 000

700 000

1 000 000

2 500 000

5 000 000

7 000 000

10 000 000

20 000 000

30 000 000

40 000 000

10

30

50

69

99

195

300

336

367

409

425

433

(*) Where the size of the total population over 12 months of age is not known, the sample size shall be based on the total

population over six months of age.

III. MONITORING IN HIGHER RISK ANIMALS

Monitoring in higher risk animals

In addition to the monitoring programmes set out in Parts I and II, Member States may on a voluntary basis carry out
targeted surveillance for TSE in higher risk animals, such as:

— animals originating from countries with indigenous TSE,
— animals which have consumed potentially contaminated feedingstuffs,
— animals born or derived from TSE-infected dams.

IV. COMMON PROVISIONS

Member States shall ensure that no parts of the body of animals sampled pursuant to this Annex are used for human
food, animal feed and fertilisers, until the laboratory examination has been concluded with negative results.

CHAPTER B

I.

INFORMATION TO BE PRESENTED BY MEMBER STATES IN THEIR REPORTS

1. the number of suspected cases per animal species placed under movement restrictions in accordance with

Article 12(1);

2. the number of suspected cases per animal species subject to laboratory examination in accordance with Article

12(2) and the outcome of the examination;

3. the estimated size of each sub-population referred to in Chapter A, Part I, point 1;

4. the number of bovine animals tested within each sub-population as referred to in Chapter A, Part I, point 1, and in

Chapter A, Part III, the method for sample selection and the outcome of the tests;

5. the number of ovine and caprine animals examined within each sub-population as referred to in Chapter A, Part II,

point 1, and in Chapter A, Part III, and the outcome of the examination;

6. number, age distribution and geographical distribution of positive cases of BSE and scrapie. The year and, where
possible, month of birth should be given for BSE cases born after the introduction of a ban on using ruminant
protein in animal feed;

7. positive TSE cases confirmed in animals other than bovine, ovine, and caprine animals.

31.5.2001

EN

Official Journal of the European Communities

L 147/19

II.

INFORMATION TO BE PRESENTED BY THE COMMISSION IN ITS SUMMARY

The summary shall be presented in a tabled format covering at least the following information for each Member State:

1. the total population of bovine animals over 24 months of age and the estimated size of each sub-population

referred to in Chapter A, Part I, point 1;

2. the number of suspected cases per animal species as referred to in Article 12;

3. the number of bovine animals tested as referred to in Chapter A, Part I, point 1;

4. the number of ovine and caprine animals examined as referred to in Chapter A, Part II, point 1;

5. the number and age distribution of positive BSE cases;

6. positive BSE cases born after the introduction of a feed ban and the year and month of birth;

7. positive cases of scrapie;

8. positive TSE cases in animals other than bovine, ovine and caprine animals.

III. RECORDS

1. The competent authority shall keep, for seven years, records of:

— the number and types of animals placed under movement restrictions as referred to in Article 12(1);
— the number and outcome of clinical and epidemiological
investigations as referred to in Article 12(1);
— the number and outcome of laboratory examinations as referred to in Article 12(2);
— the number, identity and origin of animals sampled in the framework of the monitoring programmes as

referred to in Part I and, where possible, age, breed and anamnestic information.

2. The investigating laboratory shall keep, for seven years, all records of testing, in particular laboratory workbooks,

paraffin blocks and, where appropriate, photographs of Western blots.

L 147/20

EN

Official Journal of the European Communities

31.5.2001

ANNEX IV

ANIMAL FEEDING

1. In Member States or regions thereof placed in category 5, the prohibition referred to in Article 7(1) shall be extended

to:

(a) the feeding to any farmed animal of protein derived from mammals;

(b) the feeding to any mammal of processed animal protein derived from mammals; this prohibition shall not apply to

feeding to dogs and cats nor to the production of dog and cat food;

(c) the feeding to any ruminant of rendered ruminant fat.

2. The prohibition laid down in Article 7(1) and (2) shall not apply to the following products from healthy animals:

(a) milk and milk products;

(b) gelatine derived from hides and skins;

(c) hydrolysed proteins with a molecular weight below 10 000 daltons which:

(i) have been derived from hides and skins obtained from animals which have been slaughtered in a slaughter-
house and have undergone an ante mortem inspection by an official veterinarian in accordance with Chapter
VI of Annex I to Directive 64/433/EEC and passed fit, as a result of such inspection, for slaughter for the
purpose of that Directive,
and

(ii) have been produced by a production process which involves appropriate measures to minimise contamination
of hides and skins, preparation of the hides and skins by brining, liming and intensive washing followed by
exposure of the material to a pH of more than 11 for more than three hours at a temperature of more than
80 °C and followed by heat treatment of more than 140 °C for 30 minutes at more than 3,6 bar or by an
equivalent production process approved by the Commission after consultation of the appropriate Scientific
Committee in accordance with the procedure laid down in Article 24(2),
and

(iii) come from establishments which carry out an own checks programme (HACCP);

(d) dicalcium phosphate (with no trace of protein or fat);

(e) dried plasma and other blood products, with the exception of bovine blood products for feeding to ruminants.

31.5.2001

EN

Official Journal of the European Communities

L 147/21

ANNEX V

SPECIFIED RISK MATERIAL

1. The following tissues shall be designated as specified risk material depending on the category of the Member State or

third country of origin or residence of the animal, determined in accordance with Article 5:

CATEGORIES 1 AND 2

None.

CATEGORIES 3 AND 4

(a) the skull including the brain and eyes, the tonsils and the spinal cord of bovine animals aged over 12 months, and

the intestines from the duodenum to the rectum of bovine animals of all ages;

(b) the skull including the brain and eyes, the tonsils and the spinal cord of ovine and caprine animals aged over 12
months or which have a permanent incisor erupted through the gum, and the spleen of ovine and caprine animals
of all ages.

CATEGORY 5

(a) the entire head (excluding the tongue), including the brain, eyes, trigeminal ganglia and tonsils; the thymus; the
spleen and the spinal cord of bovine animals aged over six months, and the intestines from the duodenum to the
rectum of animals of all ages;

(b) the vertebral column,

including dorsal root ganglia, of bovine animals aged over 30 months;

(c)

the skull including the brain and eyes, the tonsils, the spinal cord of ovine and caprine animals aged over 12
months or which have a permanent incisor erupted through the gum, and the spleen of ovine and caprine animals
of all ages.

2. Specified risk material must be removed at:

(a) slaughterhouses;

(b) cutting plants, high-risk processing plants or premises referred to in Articles 3 and 7 of Directive 90/667/EEC (1),
under the supervision of a designated agent appointed by the competent authority. Those establishments shall be
approved for that purpose by the competent authority.

However, the vertebral column may be removed at points of sale to the consumer situated in the territory of the
Member State concerned.

Where specified risk material
is not removed from dead animals which have not been slaughtered for human
consumption, the parts of the body containing specified risk material or the entire body will be treated as specified risk
material.

3. All specified risk material must be stained with a dye and, as appropriate, marked with a marker immediately on

removal, and completely destroyed:

(a) by incineration without pre-processing; or,

(b) provided that the dye or marker remains detectable, after pre-processing:

(i)

in accordance with the systems described in Chapters I to IV, VI and VII of the Annex to Decision
92/562/EEC (2):

— by incineration;

— by co-incineration;

(ii) in accordance with at least the standards referred to in Annex I to Decision 1999/534/EC (3), by burial in an

approved landfill site.

4. Member States may derogate from the provisions of points 2 and 3 to allow the incineration or burial of specified risk
material or entire bodies, without prior staining, or, as appropriate, removal of the specified risk materials, in the
circumstances set out in Article 3(2) of Directive 90/667/EEC and by a method which precludes all risk of transmission
of a TSE and is authorised and supervised by the competent authority, in particular where animals have died or have
been killed in the context of disease control measures and without prejudice to Articles 12 and 13.

(1) Council Directive 90/667/EEC of 27 November 1990 laying down the veterinary rules for the disposal and processing of animal
waste, for its placing on the market and for the prevention of pathogens in feedstuffs of animal or fish origin and amending
Directive 90/425/EEC (OJ L 363, 27.12.1990, p. 51). Directive as last amended by the 1994 Act of Accession.

(2) Commission Decision 92/562/EEC of 17 November 1992 on the approval of alternative heat treatment systems for processing

high-risk material (OJ L 359, 9.12.1992, p. 23). Decision as amended by the 1994 Act of Accession.

(3) Council Decision 1999/534/EC of 19 July 1999 on measures applying to the processing of certain animal waste to protect against

transmissible spongiform encephalopathies and amending Commission Decision 97/735/EC (OJ L 204, 4.8.1999, p. 37).

L 147/22

EN

Official Journal of the European Communities

31.5.2001

5. The use of an alternative test to the removal of specified risk material may be authorised under the following

conditions:

(a) tests must be carried out in slaughterhouses on all animals eligible for the removal of specified risk material;

(b) no bovine, ovine or caprine product intended for human food or animal feed may leave the slaughterhouse before
the competent authority has received and accepted the results of the tests on all slaughtered animals potentially
contaminated if BSE has been confirmed in one of them;

(c) when an alternative test gives a positive result, all bovine, ovine and caprine material which has been potentially
contaminated in the slaughterhouse is destroyed in accordance with point 3, unless all parts of the body including
the hide of the affected animal can be identified and kept separate.

6. Member States are to carry out frequent official inspections to verify the correct application of this Annex and ensure
that measures are taken to avoid contamination, particularly in slaughterhouses, cutting plants, animal waste
processing plants, high risk processing plants or premises authorised by the Member States in accordance with Article
7 of Directive 90/667/EEC, points of sale to the consumer, landfill sites and other facilities for storage or incineration.

7. Member States shall

in particular set up a system to ensure and check that:

(a) specified risk material used in the production of products referred to in Article 1(2) are used solely for the

authorised purpose;

(b) where bovine, ovine or caprine animals enter a Member State placed in a numerically lower category, indicating a
better BSE status, than that of the animals that enter, those animals remain under official supervision until
slaughter or dispatch from its territory;

(c) specified risk material, in particular where disposal takes place at establishments or premises other than slaughter-
houses, is completely separated from other waste not destined for incineration, is collected separately and is
disposed of in accordance with points 2, 3 and 4. Member States may allow dispatch of heads or carcasses
containing specified risk material to another Member State after agreement with that other Member State both to
receive the material and to apply the specific conditions applicable to such movements.

8. Member States may send specified risk material or the material processed therefrom to other Member States for
incineration only under the conditions laid down in Article 4(2) of Decision 97/735/EC (1), where applicable.

These points may be amended at the request of a Member State to allow the dispatch of specified risk material or the
material processed therefrom to third countries for incineration. The conditions governing export shall be adopted at
the same time, by the same procedure.

(1) Commission Decision 97/735/EC of 21 October 1997 concerning certain protection measures with regard to trade in certain types
of mammalian animal waste (OJ L 294, 28.10.1997, p. 7). Decision as amended by Council Decision 1999/534/EC (OJ L 204,
4.8.1999, p. 37).

31.5.2001

EN

Official Journal of the European Communities

L 147/23

ANNEX VI

STANDARDS FOR CERTAIN PRODUCTS OF ANIMAL ORIGIN DERIVED FROM OR CONTAINING
RUMINANT MATERIAL

The use of ruminant material for the production of the following products of animal origin is prohibited as referred to in
Article 9(1):

(a) mechanically recovered meat;

(b) dicalcium phosphate intended as feedingstuffs for livestock;

(c) gelatine, unless it is produced from ruminant hides;

(d) derivatives made from rendered ruminant fat;

(e) rendered ruminant fat, unless it was produced from:

(i) discrete adipose tissue declared fit for human consumption;
(ii) raw materials which were processed in accordance with the standards referred to in Directive 90/667/EEC.

L 147/24

EN

Official Journal of the European Communities

31.5.2001

ANNEX VII

ERADICATION OF TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHY

1. The inquiry referred to in Article 13(1)(b) must identify:

(a) in the case of bovine animals:

— all other ruminants on the holding of the animal
— all embryos, ova and the last progeny of a female animal in which the disease was confirmed and the embryos
or progeny of which were collected or born within two years prior to, or after, clinical onset of the disease in
its dam;

in which the disease was confirmed;

— all animals of the cohort of the animal
— the possible origin of the disease and other holdings on which there are animals, embryos or ova which may
have become infected by the TSE agent or been exposed to the same feed or contamination source;
— the movement of potentially contaminated feedingstuffs, other material, or any other means of transmission,

in which the disease was confirmed;

which may have transmitted the TSE agent to or from the holding in question;

(b) in the case of ovine and caprine animals:

— all ruminants other than ovine and caprine animals on the holding of the animal in which the disease was

confirmed;

— insofar as they are identifiable, the parents, all embryos, ova and the last progeny of the animal in which the

disease was confirmed;

— all animals of the cohort, to be defined in accordance with the procedure laid down in Article 24(2), of the

animal

in which the disease was confirmed;

— all other ovine and caprine animals on the holding of the animal in which the disease was confirmed in

addition to those mentioned in the second and third indents;

— the possible origin of the disease and the identification of other holdings on which there are animals, embryos
or ova which may have become infected by the TSE agent or been exposed to the same feed or contamination
source;

— the movement of potentially contaminated feedingstuffs, other material or any other means of transmission,

which may have transmitted the BSE agent to or from the holding in question.

2. The measures laid down in Article 13(1) shall comprise at least:

(a) in case of confirmation of BSE in a bovine animal, killing and complete destruction of bovine animals and
destruction of embryos and ova identified by the inquiry referred to in point 1(a), first, second and third indents;

(b) in case of confirmation of BSE in an ovine or caprine animal, killing and complete destruction of all animals,

embryos and ova identified by the inquiry referred to in point 1(b), second to sixth indents.

31.5.2001

EN

Official Journal of the European Communities

L 147/25

ANNEX VIII

PLACING ON THE MARKET AND EXPORT

CHAPTER A

Conditions for intra-Community trade in live animals, embryos and ova

I. CONDITIONS WHICH APPLY IRRESPECTIVE OF THE CATEGORY OF THE MEMBER STATE OR THIRD COUNTRY

OF ORIGIN OR RESIDENCE OF THE ANIMAL

1. Dispatch to other Member States must follow the rules of Article 15(1).

2. The following conditions shall apply to the movement of bovine embryos and ova:

Bovine embryos and ova must be derived from female animals which, at the time of collection:

— were not suspected of being infected by BSE;

— themselves complied with the conditions laid down in Part II.

3. The following conditions shall apply to trade in ovine and caprine animals:

(a) Ovine and caprine animals for breeding must:

(i) come from a holding satisfying the following requirements:

— it is subject to regular official veterinary checks;

— the animals are marked;

— no case of scrapie has been confirmed for at least three years;

— checking by sampling is carried out on the holding on old female animals intended for culling;

— females are introduced into that holding only if they come from a holding which complies with the

same requirements;

(ii) have been continuously kept on a holding or holdings complying with the requirements laid down in

point (i) since birth or for the last three years;

(iii) if they are destined for a Member State which benefits, for all or part of its territory, from the provisions
laid down in point (b), comply with the guarantees provided for in the programmes referred to in that
point.

(b) A Member State which has a compulsory or voluntary national scrapie control programme for all or part of

its territory:

(i) may submit the said programme to the Commission, outlining in particular:

— the distribution of the disease in the Member State;

— the reasons for the programme, taking into consideration the importance of the disease and the

cost/benefit ratio;

— the geographical area in which the programme will be implemented;

— the status categories to be applied to the holdings, the standards which must be attained in each

category and the test procedures to be used;

— the programme monitoring procedures;

— the action to be taken if, for any reason, a holding loses its status;

— the measures to be taken if the results of checks carried out in accordance with the provisions of the

programme are positive;

(ii) the programmes referred to in point (i) may be approved in compliance with the criteria laid down in that
point in accordance with the procedure referred to in Article 24(2). According to the same procedure, the
additional guarantees, general or specific, which may be required in intra-Community trade, shall be
defined at the same time or at the latest three months after approval of the programmes. Such guarantees
must not exceed those which the Member State implements nationally;

(iii) programmes submitted by Member States may be amended or supplemented in accordance with the
procedure referred to in Article 24(2). According to the same procedure, an amendment or an addition to
a programme which has already been approved or to guarantees which have been defined in accordance
with subparagraph (ii) may be approved.

L 147/26

EN

Official Journal of the European Communities

31.5.2001

(c) Where a Member State considers that its territory or part of its territory is free from ovine scrapie:

(i) it is to submit to the Commission appropriate supporting documentation, setting out in particular:

— the history of the occurrence of the disease in its territory;

— the results of surveillance testing based on serological, microbiological, pathological or epidemi-

ological

investigation;

— the period over which the surveillance was carried out;

— the arrangements for verifying the absence of the disease;

(ii) the additional guarantees, general or specific, which may be required in intra-Community trade are to be
defined in accordance with the procedure referred to in Article 24(2). Such guarantees must not exceed
those which the Member State implements nationally;

(iii) the Member State concerned is to notify the Commission of any change in the details specified in point (i)
which relate to the disease. The guarantees defined in accordance with point (ii) may, in the light of such
notification, be amended or withdrawn in accordance with the procedure referred to in Article 24(2).

II. CONDITIONS WHICH APPLY DEPENDING ON THE CATEGORY OF THE MEMBER STATE OF ORIGIN OR

RESIDENCE OF THE ANIMAL DETERMINED IN ACCORDANCE WITH ANNEX II, CHAPTER C

1. Dispatch to other Member States is to follow the rules of Article 15(1).

2. The BSE category of the Member State of origin of bovine, ovine and caprine animals are to be communicated to

the Member State of destination.

3. The following conditions are to apply to movements as referred to in point 1 of bovine animals coming from or

having resided in the Member States or one of the regions thereof placed in:

CATEGORIES 3 AND 4

The animals must have:

(a) been born, raised and have remained in herds in which no case of BSE has been confirmed for at least seven

years; or

(b) been born after the date from which the ban on the feeding of ruminants with proteins derived from

mammals has been effectively enforced.

CATEGORY 5

The animals must have:

(a) been born after the date from which the ban on the feeding of farmed animals with proteins derived from

mammals has been effectively enforced; and

(b) been born, raised and have remained in herds in which no case of BSE has been confirmed for at least seven
years, and which contain only bovine animals born on the farm or coming from a herd of equivalent status.

CHAPTER B

Conditions relating to progeny of TSE suspect or confirmed animals referred to in Article 15(2)

It shall be prohibited to place on the market the last-born progeny to which female bovine animals infected with a TSE or
BSE-confirmed ovine or caprine animals gave birth during the preceding two-year period or during the period that
followed the appearance of the first clinical signs of the onset of the disease.

CHAPTER C

Conditions for intra-Community trade in certain products of animal origin

I. The following products of animal origin are exempt from the prohibition referred to in Article 16(3), provided that

they are derived from bovine animals that satisfy the requirements of Parts II or III below:

— fresh meat;

— minced meat;

— meat preparations;

— meat products;

— petfood which is destined for domestic carnivores.

31.5.2001

EN

Official Journal of the European Communities

L 147/27

Date-based Scheme

II. Deboned fresh meat from which all adherent tissues, including obvious nervous and lymphatic tissue, has been
removed, and products of animal origin referred to in Part I deriving therefrom obtained from eligible animals from
countries or regions in category 5 may be marketed in accordance with the second subparagraph of Article 16(3)
when they are obtained from animals born after the date from which the animal feeding standards laid down in
Article 7(2) were effectively enforced and certified as meeting the conditions laid down in point 1 and they are
produced in establishments which meet the condition laid down in point 9. The competent authority shall ensure
that the conditions with respect to controls laid down in points 2 to 8 and point 10 are complied with.

1. A bovine animal shall be eligible for the Date-based Scheme if it was born and raised in the Member State

concerned and if at the time of slaughter it is shown that the following conditions are fulfilled:

(a) the animal has been clearly identifiable throughout its life, enabling it to be traced back to its dam and herd
of origin; its unique eartag number, date and holding of birth and all movements after birth are recorded
either in the animal's official passport or in an official computerised identification and tracing system; the
identity of its dam is known;

(b) the animal is more than six months but less than 30 months of age, determined by reference to an official

computer record of its date of birth, or to the animal's official passport;

(c) the competent authority has obtained and verified positive evidence that the dam of the animal has lived for

at least six months after the birth of the eligible animal;

(d) the dam of the animal has not developed BSE and is not suspected of having contracted BSE.

C o n t r o l s

2. If any animal presented for slaughter or any circumstance surrounding its slaughter does not meet all of the
requirements of this Regulation, the animal must be automatically rejected and its passport confiscated. If that
information becomes available after slaughter, the competent authority must immediately cease issuing certi-
ficates and cancel certificates issued. If dispatch has already taken place, the competent authority must notify the
competent authority of the place of destination. The competent authority of the place of destination must take
the appropriate measures.

3. Slaughter of eligible animals must take place in slaughterhouses which are not used for the slaughter of bovine

animals other than those slaughtered under a Date-based Scheme or under a Certified Herd Scheme.

4. The competent authority must satisfy itself that procedures used in the cutting plants ensure that the following

lymph nodes have been removed:

popliteal,
costocervical, sternal, prescapular, axilliary, caudal and deep cervical.

inguinal, deep inguinal, medial and lateral

ischiatic, superficial

iliac, renal, prefemoral,

lumbar,

5. Meat must be traceable back to the eligible animal, or after cutting, to the animals cut in the same batch, by
means of an official tracing system until the time of slaughter. After slaughter, labels must be capable of tracing
fresh meat and products referred to in Part I back to the eligible animal to enable the consignment concerned to
be recalled. In the case of petfood, accompanying documents and records must allow tracing.

6. All approved eligible carcasses must have individual numbers correlated with the eartag number.

7. The Member State must have detailed protocols in place covering:

(a) tracing and controls prior to slaughter;

(b) controls during slaughter;

(c) controls during processing of petfood;

(d) all

labelling and certification requirements after slaughter to the point of sale.

8. The competent authority must set up a system for recording checks on compliance so that control can be

demonstrated.

L 147/28

EN

Official Journal of the European Communities

31.5.2001

T h e e s t a b l i s h m e n t

9. To obtain approval, the establishment must devise and implement a system whereby the eligible meat and/or
eligible product is identifiable and all meat can be traced back to the eligible animal, or after cutting, to the
animals cut in the same batch. The system must allow full traceability of the meat or products of animal origin at
all stages and records must be retained for at least two years. Details of the system employed must be given, in
writing, by the management of the establishment to the competent authority.

10. The competent authority must assess, approve and monitor the system provided by the establishment in order to

ensure that it provides full segregation and traceability both backwards and forwards.

Certified herd Scheme

III. Deboned fresh meat from which all adherent tissues, including obvious lymphatic and nervous tissue, has been
removed, and products of animal origin referred to in Part I, deriving therefrom which are obtained from eligible
animals from countries or regions in category 5, may be marketed in accordance with the second subparagraph of
Article 16(3) when obtained from animals which are certified as meeting the conditions laid down in point 2 and
coming from herds in which no case of BSE has occurred in the last seven years and which are certified as meeting
the conditions laid down in point 1 and produced in establishments which meet the condition laid down in point 11.
The competent authority shall ensure that the conditions laid down in points 3 to 10 and 12 with respect to the
computerised tracing system and the controls are complied with.

C o n d i t i o n s r e l a t i n g t o h e r d s

1. (a) A herd is a group of animals forming a separate and distinct unit, that is a group of animals which is
managed, housed and kept separately from any other group of animals and which is identified with unique
herd and animal

identification numbers.

(b) A herd is eligible when for at least seven years there has been no confirmed case of BSE, nor a suspect case
for which the diagnosis of BSE has not been ruled out, in any animal which was still in or had moved
through or from the herd.

(c) As an exception to the provisions in point (b), a herd that has been in existence for less than seven years may
be considered eligible, after a thorough investigation by the competent veterinary authority, on condition
that:

(i) all animals born or moved into the newly established herd complied with the conditions set out in point

(2)(a), (d) and (e); and,

(ii) the herd has complied with the conditions set out in point (b) during its entire existence.

(d) If a herd is newly established on a holding which experienced a confirmed case of BSE in any animal which
was still in or had moved through or from a herd on that holding, the newly established herd can only be
eligible after a thorough investigation by the competent veterinary authority, certifying compliance with each
of the following conditions to the satisfaction of that authority:

(i) all animals of the affected herd previously held on the same holding have been removed or killed;

(ii) all feed has been removed and destroyed and all feed containers thoroughly cleansed;

(iii) all buildings have been emptied and thoroughly cleansed before the new animals were admitted;

(iv) all conditions set out in point (c) have been complied with.

C o n d i t i o n s r e l a t i n g t o t h e a n i m a l

2. (a) all records of the animal's birth, identity and movements are recorded on an official computerised tracing

system;

(b) the animal is more than six months but less than 30 months of age, determined by reference to an official

computer record of its date of birth;

(c) its dam has lived for at least six months after its birth;

(d) its dam has not developed BSE and is not suspected of having contracted BSE;

(e) the herd of birth of the animal and all herds through which it has moved are eligible.

31.5.2001

EN

Official Journal of the European Communities

L 147/29

C o m p u t e r i s e d t r a c i n g s y s t e m

3. The official computerised tracing system referred to in point 2(a) will be approved only where it has been in
operation for sufficient time to contain all the information, relating to the lifetime and movements of the
animals, needed to check compliance with the requirements of this Regulation, and concerns only animals born
after the system came into operation. Historical data loaded into a computer for any period before the system
was operational will not be accepted for this purpose.

C o n t r o l s

4. If any animal presented for slaughter or any circumstance surrounding its slaughter does not meet all of the
requirements of this Regulation, the animal must be automatically rejected and its passport confiscated. If that
information becomes available after slaughter, the competent authority must immediately cease issuing certi-
ficates, and cancel certificates issued. If dispatch has already taken place, the competent authority must notify the
competent authority of the place of destination. The competent authority of the place of destination must take
the appropriate measures.

5. Slaughter of eligible animals must take place in slaughterhouses used exclusively for the slaughter of animals

under a Date-based Scheme or under a Certified Herd Scheme.

6. The competent authority must satisfy itself that procedures used in the cutting plants ensure that the following

lymph nodes have been removed:

popliteal,
costocervical, sternal, prescapular, axilliary, caudal and deep cervical.

inguinal, deep inguinal, medial and lateral

ischiatic, superficial

iliac, renal, prefemoral,

lumbar,

7. Meat must be traceable back to the herd of the eligible animal, or after cutting, to the animals cut in the same
batch, by means of the computerised tracing system until the time of slaughter. After slaughter, labels must be
capable of tracing fresh meat and products referred to in Part I back to the herd to enable the consignment
concerned to be recalled. In the case of petfood, accompanying documents and records must allow tracing.

8. All approved eligible carcasses must have individual numbers correlated with the eartag number.

9. The Member State must have detailed protocols in place covering:

(a) tracing and controls prior to slaughter;

(b) controls during slaughter;

(c) controls during processing of petfood;

(d) all

labelling and certification requirements after slaughter to the point of sale.

10. The competent authority must set up a system for recording checks on compliance so that control can be

demonstrated.

T h e e s t a b l i s h m e n t

11. To obtain approval, the establishment must devise and implement a system whereby the eligible meat and/or
eligible product is identifiable and all meat can be traced back to its herds of origin, or after cutting, to the
animals cut in the same batch. The system must facilitate full traceability of the meat or products of animal
origin at all stages and records must be retained for at least two years. Details of the system employed must be
given,

in writing, by the management of the establishment to the competent authority.

12. The competent authority must assess, approve and monitor the system provided by the establishment in order to

ensure that it provides full segregation and traceability both backwards and forwards.

CHAPTER D

Conditions applicable to exports

Live bovine animals and products of animal origin derived therefrom are to be subject — as regards exports to third
countries — to the rules laid down in this Regulation for intra-Community trade.

L 147/30

EN

Official Journal of the European Communities

31.5.2001

IMPORTATION INTO THE COMMUNITY OF LIVE ANIMALS, EMBRYOS, OVA AND PRODUCTS OF ANIMAL
ORIGIN

ANNEX IX

CHAPTER A

When importing from countries or regions placed in category 1, the competent authority is, for bovine animals and all
commodities of bovine origin for which this Regulation lays down specific rules, to take account of the presentation of an
international animal health certificate attesting that the country or region complies with the conditions in Annex II,
Chapter C, to be placed in that category.

CHAPTER B

Imports of bovine animals

A. Imports of bovine animals from a country or a region placed in category 2 are to be subject to the presentation of an

international animal health certificate attesting that:

(a) the feeding of ruminants with proteins derived from mammals has been banned and the ban has been effectively

enforced;

(b) the bovine animals intended for export to the Community are identified by a permanent identification system
enabling them to be traced back to the dam and herd of origin and are not the progeny of BSE-suspected females.

B. Imports of bovine animals from countries or regions placed in category 3 are to be subject to the presentation of an

international animal health certificate attesting that:

1. the feeding of ruminants with proteins derived from mammals has been banned and the ban has been effectively

enforced;

2. bovine animals intended for export to the Community:

— are identified by a permanent identification system enabling them to be traced back to the dam and herd of
origin and making it possible to establish that they are not the progeny of BSE suspect or confirmed females;

— were born, raised and had remained in herds in which no case of BSE had been confirmed for at least seven

years; or

— were born after the date from which the ban on the feeding of ruminants with proteins derived from mammals

has been effectively enforced.

C. Imports of bovine animals from countries or regions placed in category 4 are to be subject to the presentation of an

international animal health certificate attesting that:

1. the feeding of ruminants with proteins derived from mammals has been banned and the ban has been effectively

enforced;

2. bovine animals intended for export to the Community:

(a) are identified by a permanent identification system enabling them to be traced back to the dam and herd of
origin and making it possible to establish that they are not the progeny of BSE suspect or confirmed females;
and

(b) were born, raised and have remained in herds in which no case of BSE has been confirmed for at least seven

years; or

(c) were born after the date from which the ban on the feeding of ruminants with proteins derived from mammals

has been effectively enforced.

D. Imports of bovine animals from countries or regions placed in category 5 are to be subject to the presentation of an

international animal health certificate attesting that:

1. the feeding of farmed animals with proteins derived from mammals has been banned and the ban has been

effectively enforced;

2. the affected bovine animals are killed and completely destroyed as well as:

(a) if these are females, their last progeny born within two years prior to, or after the first clinical signs of the

onset of the disease;

(b) all bovine animals from the same cohort

if such animals are still alive in the country or region;

31.5.2001

EN

Official Journal of the European Communities

L 147/31

3. the animals intended for export to the Community:

(a) were born after the date from which the ban on the feeding of farmed animals with proteins derived from

mammals was effectively enforced;

(b) are identified by a permanent identification system enabling them to be traced back to the dam and herd of

origin and are not the progeny of BSE suspect or confirmed females;

AND

(c) either were born, raised and have remained in herds in which no case of BSE has ever been confirmed, and
which contain only bovine animals born on the farm or coming from a herd of equal health status; or

(d) were born, raised and have remained in herds in which no case of BSE has been confirmed for at least seven
years, and which contain only bovine animals born on the farm or coming from a herd of equal health status.

CHAPTER C

Imports of fresh meat and products of bovine animal origin

A. Imports of fresh meat (on the bone or deboned) and products of bovine animal origin from countries or regions
placed in category 2 are to be subject to the presentation of an international health certificate attesting that the feeding
of ruminants with proteins derived from mammals has been banned and the ban has been effectively enforced.

B. Imports of fresh meat (on the bone or deboned) and products of bovine animal origin from countries or regions
placed in category 3 are to be subject to the presentation of an international health certificate attesting that:

(a) the feeding of ruminants with proteins derived from mammals has been banned and the ban has been effectively

enforced;

(b) the fresh meat and products of bovine animal origin intended for export to the Community do not contain or are
not derived from specified risk material referred to in Annex V or mechanically recovered meat obtained from the
bone of the head or vertebral column.

C. Imports of fresh meat (on the bone or deboned) and meat products of bovine origin from countries or regions placed

in category 4 are to be subject to the presentation of an international health certificate attesting that:

1. the feeding of ruminants with proteins derived from mammals has been banned and the ban has been effectively

enforced;

2. the fresh meat and products of bovine animal origin intended for export to the Community do not contain or are
not derived from specified risk material referred to in Annex V or mechanically recovered meat obtained from the
head or vertebral column.

D. Imports of fresh meat and products of bovine animal origin from countries or regions placed in category 5 are to be
prohibited except for the products of animal origin listed in section I of Chapter C, Annex VIII. These imports are to
be subject to the presentation of an international health certificate attesting that:

1. they fulfil the conditions of Article 16(2) and those set out in sections II or III of Chapter C of Annex VIII;

2. the meat products intended for export to the Community do not contain or are not derived from any product

referred to in Chapter F, nor from any specified risk material as defined in Annex V;

3. a system is in operation enabling the fresh meat and products of bovine animal origin intended for export to the

Community to be traced back to the establishments from which they are derived;

4. the bovine animals from which the meat or meat products intended for export to the Community originate:

(a) were identified by a permanent identification system enabling them to be traced back to the dam and herd of

origin;

(b) are not the progeny of BSE-suspect or confirmed females; and either:

— were born after the date from which the ban on the feeding of farmed animals with proteins derived from

mammals was effectively enforced; or

— were born, raised and have remained in herds in which no case of BSE has been confirmed for at least

seven years;

5. the feeding of farmed animals with proteins derived from mammals has been banned and the ban has been

effectively enforced;

L 147/32

EN

Official Journal of the European Communities

31.5.2001

6. the affected bovine animals are slaughtered and completely destroyed as well as:

(a) if these are females, their last progeny born within two years prior to, or after, the first clinical signs of the

onset of the disease;

(b) all bovine animals from the same cohort

if they are still alive in the country or region.

CHAPTER D

Imports of bovine embryos and ova

A. Imports of bovine embryos/ova from countries or regions placed in category 2 are to be subject to the presentation of

an international animal health certificate attesting that:

1. the feeding of ruminants with proteins derived from mammals has been banned and the ban has been effectively

enforced;

2. the embryos/ova were collected, processed and stored in conformity with the provisions of Annexes A and B to

Directive 89/556/EC (1).

B. Imports of bovine ova/embryos from countries or regions placed in category 3 are to be subject to the presentation of

an international animal health certificate attesting that:

1. the feeding of ruminants with proteins derived from mammals has been banned and the ban has been effectively

enforced;

2. ova/embryos destined for export to the Community are derived from females which:

(a) are identified by a permanent identification system enabling them to be traced back to the dam and herd of

origin, and are not the progeny of BSE-confirmed females;

(b) are not the progeny of BSE-suspect or confirmed females;

(c) were not suspected of being affected by BSE at the time of embryo collection;

3. the ova/embryos were collected, processed and stored in accordance with the provisions of Annexes A and B to

Directive 89/556/EEC.

C. Imports of ova/embryos from countries or regions placed in category 4 are to be subject to the presentation of an

international animal health certificate attesting that:

1. the feeding of ruminants with proteins derived from mammals has been banned and the ban has been effectively

enforced;

2. the ova/embryos intended for export to the Community are derived from females which:

(a) are identified by a permanent identification system enabling them to be traced back to the dam and herd of

origin, and are not the progeny of BSE-suspected or affected females;

(b) are not affected with BSE;

(c) were not suspected of being affected with BSE at the time of embryo collection; and

(i) either were born after the date from which the ban on the feeding of ruminants with proteins derived from

mammals was effectively enforced; or

(ii) were born, raised and have remained in herds in which no case of BSE has been confirmed for at least

seven years;

3. the ova/embryos were collected, processed and stored in conformity with the provisions of Annexes A and B to

Directive 89/556/EEC.

D. Imports of bovine ova/embryos from countries or regions placed in category 5 are to be subject to the presentation of

an international animal health certificate attesting that:

1. the feeding of animals for breeding with proteins derived from mammals has been banned and the ban has been

effectively enforced;

2. the affected bovine animals, and, if these are females, their last progeny born within two years prior to, or after,

clinical onset of the disease,

if alive in the country or region, are killed and completely destroyed;

3. ova/embryos intended for export to the Community are derived from females which:

(a) are identified by a permanent identification system enabling them to be traced back to the dam and herd of

origin, and are not the progeny of BSE-suspected or confirmed females;

(b) are not affected with BSE;

(1) Council Directive 89/556/EEC of 25 September 1989 on animal health conditions governing intra-Community trade in importation
from third countries of embryos of domestic animals of the bovine species (OJ L 302, 19.10.1989, p. 1). Directive as last amended
by Commission Decision 94/113/EC (OJ L 53, 24.2.1994, p. 23).

31.5.2001

EN

Official Journal of the European Communities

L 147/33

(c) were not suspected of being affected with BSE at the time of embryo collection; and

(i) either were born after the date from which the ban on the feeding of animals for breeding with proteins

derived from mammals was effectively enforced;

(ii) or have never been fed with proteins derived from mammals and were born, raised and have remained in
herds in which no case of BSE has been confirmed for at least seven years, and which contain only bovine
animals born on the farm or coming from a herd of equal health status;

4. the ova/embryos were collected, processed and stored strictly in conformity with the provisions of Annexes A and

B to Directive 89/556/EEC.

CHAPTER E

Imports of ovine and caprine animals

Ovine and caprine animals imported into the Community are to meet the requirements which provide health guarantees
equivalent to those required by this Regulation or pursuant to this Regulation.

CHAPTER F

Imports into the Community from third countries or regions thereof, placed in category 5, of the products of animal
origin referred to in Annex VIII, Chapter C, in accordance with Article 16(3) are to be prohibited if they contain or are
derived from the following products or material derived from ruminant animals:
— mechanically recovered meat;
— dicalcium phosphate intended for feeding livestock;
— gelatine unless produced from hides or skins;
— rendered ruminant fat and derivatives made from it unless they were produced from discrete adipose tissue which was
itself declared fit for human consumption, or from raw materials which were processed in accordance with the
standards referred to in Decision 1999/534/EC.

CHAPTER G

When importing products of animal origin from third countries or regions thereof which are not placed in category 1, the
appropriate certificates, as required by Community legislation, are to be supplemented by a declaration signed by the
competent authority of the country of production, worded as follows:

‘The product of animal origin does not contain, and is not derived from, specified risk material as defined in Annex V
to Regulation (EC) No 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules
for the prevention, control and eradication of certain transmissible spongiform encephalopathies or mechanically
recovered meat obtained from bones of the head or vertebral column of bovine animals. The animals have not been
slaughtered after stunning by means of a gas injected into the cranial cavity or killed instantaneously by the same
method or slaughtered by laceration after stunning of central nervous tissue by means of an elongated rod-shaped
instrument introduced into the cranial cavity.’

L 147/34

EN

Official Journal of the European Communities

31.5.2001

REFERENCE LABORATORIES, SAMPLING AND LABORATORY ANALYSIS METHODS

ANNEX X

CHAPTER A

National reference laboratories

1.

The designated national reference laboratory is to:

(a) have at its disposal facilities and expert personnel enabling it to show at all times, and especially when the
disease in question first appears, the type and strain of the agent of TSE, and to confirm results obtained by
regional diagnostic laboratories. Where it is not capable of identifying the strain-type of the agent, it shall set
up a procedure to ensure that the identification of the strain is referred to the Community reference laboratory;

(b) verify diagnostic methods used in regional diagnostic laboratories;

(c) be responsible for coordination of diagnostic standards and methods within the Member State. To this end, it:

— may provide diagnostic reagents to laboratories approved by the Member State;

— is to control the quality of all diagnostic reagents used in the Member State;

— is to periodically arrange comparative tests;

— is to hold isolates of the agents of the disease in question, or corresponding tissues containing such agents,

coming from cases confirmed in the Member State;

— is to ensure confirmation of results obtained in diagnostic laboratories designated by the Member State;

(d) is to cooperate with the Community reference laboratory.

2.

However, by way of derogation from point 1, Member States which do not have a national reference laboratory are
to use the services of the Community reference laboratory or of national reference laboratories in other Member
States.

3.

The national reference laboratories are:

Austria:

Belgium:

Bundesanstalt für Tierseuchenbekämpfung, Mödling
Robert Koch Gasse 17
A-2340 Mödling

CERVA-CODA-VAR
Centre d'Étude et de Recherches Vétérinaires et Agrochimiques
Centrum voor Onderzoek in Diergeneeskunde en Agrochemie
Veterinary and Agrochemical Research Centre
Groeselenberg 99
B-1180 Bruxelles

Denmark:

Danish Veterinary Laboratory
Bülowsvej 27
DK-1790 Copenhagen V

Finland:

France:

Eläinlääkintä- ja elintarvikelaitos
Hämeentie 57
FIN-00550 Helsinki

Agence Française de Sécurité Sanitaire des Aliments
Laboratoire de pathologie bovine
31, avenue Tony Garnier
BP 7033
F-69342 Lyon Cedex

31.5.2001

EN

Official Journal of the European Communities

L 147/35

Germany:

Bundesforschungsanstalt für Viruskrankheiten der Tiere
Anstaltsteil Tübingen
Postfach 1149
D-72001 Tübingen

Greece:

1. Department of Pathology, Faculty of Veterinary Medicine

University of Thessaloniki
Giannitson & Voutyra St.
GR-54627 Thessaloniki

2. Athens Centre of Veterinary Institutes

Laboratory of Pathology
25 Neapoleos St.
GR-14310 Athens

The Central Veterinary Research Laboratory
Abbotstown
Castleknock
Dublin 15
Ireland

Istituto Zooprofilattico Sperimentale del Piemonte
Liguria e Valle d'Aosta
CEA
Via Bologna
I-148-10150 Torino

Laboratoire ‘CERVA’
CODA-VAR
Centre d'Etude et de Recherches Véterinaires et Agrochimiques
Groeselenberg 99
B-1180 Bruxelles

Instituut voor Dierhouderij en Diergezondheid
Edelhertweg 15
Postbus 65
8200 AB Lelystad
Netherlands

Ireland:

Italy:

Luxembourg:

Netherlands:

Portugal:

Laboratório Nacional de Investigação Veterinária
Estrada de Benfica, 701
P-1500 Lisboa

Spain:

1. Laboratorio de la Facultad de Veterinaria

Departamento de Patología Animal (Anatomía Patológica)
Zaragoza
Spain

2. Laboratorio Central de Veterinaria de Algete

Madrid
Spain

(Only BSE tests as referred to in Annex IVA of Decision 98/272/EC)

Sweden:

United
Kingdom

The National Veterinary Institute
S-75189 Uppsala

The Veterinary Laboratories Agency
Woodham Lane
New Haw
Addlestone
Surrey KT15 3NB
United Kingdom

CHAPTER B

Community reference laboratory

1.

The Community reference laboratory for TSEs is:

The Veterinary Laboratories Agency
Woodham Lane
New Haw
Addlestone
Surrey KT15 3NB
United Kingdom

L 147/36

EN

Official Journal of the European Communities

31.5.2001

2.

The functions and duties of the Community reference laboratory are:

(a) to coordinate,

in consultation with the Commission, the methods employed in the Member States for

diagnosing BSE, specifically by:

— storing and supplying corresponding tissues containing the agent, for the development or production of the

relevant diagnostic tests or for typing strains of the agent;

— supplying standard sera and other reference reagents to the national reference laboratories in order to

standardise the tests and reagents used in the Member States;

— building up and retaining a collection of corresponding tissues containing the agents and strains of TSEs;

— organising periodic comparative tests of diagnostic procedures at Community level;

— collecting and collating data and information on the methods of diagnosis used and the results of tests

carried out in the Community;

— characterising isolates of the TSE agent by the most up-to-date methods to allow greater understanding of

the epidemiology of the disease;

— keeping abreast of trends in surveillance, epidemiology and prevention of TSEs throughout the world;

— maintaining expertise on prion diseases to enable rapid differential diagnosis;

— acquiring a thorough knowledge of the preparation and use of diagnostic methods used to control and

eradicate TSEs;

(b) to assist actively in the diagnosis of outbreaks of TSEs in Member States by studying samples from TSE-infected

animals sent for confirmatory diagnosis, characterisation and epidemiological studies;

(c) to facilitate the training or retraining of experts in laboratory diagnosis with a view to the harmonisation of

diagnostic techniques throughout the Community.

CHAPTER C

Sampling and laboratory testing

1.

Sampling and laboratory testing for the presence of BSE in bovine animals

1.1.

C o l l e c t i o n o f s a m p l e s

The competent authority shall ensure that samples are collected using the methods and protocols laid down in the
latest edition of the Manual of Standards for Diagnostic Tests and Vaccines of the International Office of Epizootic
Diseases (OIE),
(hereinafter referred to as the ‘Manual’). In the absence of such methods and protocols, the
competent authority shall ensure that the samples are collected in a manner appropriate for the correct application
of tests.

1.2.

L a b o r a t o r y t e s t i n g

1.2.1. Suspect cases

Tissues from bovine animals sent for laboratory testing in accordance with Article 12(2) shall be subject to a
histopathological examination as laid down in the latest edition of the Manual, except where the material is
autolysed. Where the result of the histopathological examination is inconclusive or negative or where the material
is autolysed, the tissues shall be subjected to an examination by one of the other diagnostic methods laid down in
the above Manual (immonucytochemistry, immuno-blotting or demonstration of characteristic fibrils by electron
microscopy).

1.2.2. Animals examined in the framework of the annual monitoring programme

Bovine animals examined in the framework of the annual monitoring programme as laid down in Annex III,
Chapter A, point I, and the targeted surveillance programme provided for in Annex III, Chapter A, Part III, shall be
examined by one of the tests listed in point 4.

Where the result of the rapid test is inconclusive or positive, the tissues shall be subject to a histopathological
examination of the brainstem as laid down in the latest edition of the Manual, except where the material is
autolysed or otherwise not suitable for examination by histopathology. Where the result of the histopathological
examination is inconclusive or negative or where the material is autolysed, the tissues shall be subjected to an
examination by one of the other diagnostic methods mentioned in 1.2.1; however, the method must not be the
same as the method used in the screening test.

31.5.2001

EN

Official Journal of the European Communities

L 147/37

1.3.

I n t e r p r e t a t i o n o f

r e s u l t s

An animal examined as referred to in point 1.2.1 shall be regarded a positive BSE case, if the result of one of the
tests is positive.

An animal examined as referred to in point 1.2.2 shall be regarded as a positive BSE case if the result of the
screening test is positive or inconclusive, and

— the result of the subsequent histopathological examination is positive, or
— the result of another diagnostic method mentioned in point 1.2.1 is positive.

2.

Sampling and laboratory testing for the presence of a TSE in ovine and caprine animals

Sampling and laboratory testing for the presence of scrapie in ovine and caprine animals shall be carried out in
accordance with the methods and protocols laid down in the latest edition of the Manual.

Rules concerning sampling and laboratory testing for the presence of BSE in ovine and caprine animals shall be
drawn up in accordance with the procedure referred to in Article 24(2).

3.

Confirmation of the presence of other TSEs

The tests carried out to confirm the suspected presence of a TSE different from those referred to in points 1 and 2
shall include at least a histopathological examination of brain tissue. The competent authority may also require
laboratory tests such as immunocytochemical and immunodiagnostic tests for the detection of scrapie-associated
fibrils if it deems it necessary. In any case at least one other laboratory examination should be carried out in
accordance with the previous sentence if the initial histopathological examination proves negative. The three tests
must be carried out in the event of the first appearance of the disease.

4.

Rapid tests

For the purposes of carrying out the tests in accordance with Article 5(3) and Article 6(1), the following methods
shall be used as rapid tests within the meaning of this Regulation:

— Western blot test for the detection of the protease-resistant fragment PrPRes (Prionics Check test);
— Chemiluminescent ELISA test involving an extraction method and an ELISA technique, using an enhanced

chemiluminescent reagent (Enfer test);

— Sandwich immunoassay for PrPRes carried out following denaturation and concentration steps (BIORADE test).

5.

Alternative tests

(To be defined)

L 147/38

EN

Official Journal of the European Communities

31.5.2001

ANNEX XI

TRANSITIONAL MEASURES

TRANSITIONAL MEASURES REFERRED TO IN ARTICLE 22

A. Concerning the removal of specified risk material

1. Member States shall ensure that the specified risk material designated below is removed and destroyed in accordance

with points 6 to 11.

(a) The following tissues are designated as specified risk material:

(i) the skull including the brain and eyes, the tonsils and the spinal cord of bovine animals aged over 12 months,

and the intestines from the duodenum to the rectum of bovine animals of all ages;

(ii) the skull including the brain and eyes, the tonsils and the spinal cord of ovine and caprine animals aged over
12 months or which have a permanent incisor erupted through the gum, and the spleen of ovine and caprine
animals of all ages.

(b) In addition to the specified risk material listed in (a), the following tissues must be designated as specified risk
material in the United Kingdom of Great Britain and Northern Ireland and in Portugal, with the exception of the
Autonomous Region of the Azores:

(i) the entire head excluding the tongue, including the brain, eyes, trigeminal ganglia and tonsils; the thymus, the
spleen and the spinal cord of bovine animals aged over six months, and the intestines from the duodenum to
the rectum of bovine animals of all ages;

(ii) the vertebral column,

including dorsal root ganglia, of bovine animals aged over 30 months.

2. Specified risk material or processed material derived from it may be despatched only with a view to subsequent

incineration,

in accordance with point 11 or, where appropriate, point 7(b).

3. Member States shall ensure that bones from the head and vertebral column of bovine, ovine and caprine animals are

not used for the production of mechanically recovered meat.

4. Member States shall ensure that laceration after stunning of central nervous tissue by means of an elongated
rod-shaped instrument introduced into the cranial cavity is not effected within their territory with regard to bovine,
ovine or caprine animals whose meat is intended for human or animal consumption.

5. The specified risk material referred to in point 1(a) shall not be imported into the Community after 31 March 2001.

The products of animal origin listed below shall be subject to restrictions on import into the Community:

— fresh meat: the meat defined by Directive 64/433/EEC,

— minced meat and meat preparations: the minced meat and meat preparations defined by Directive 94/65/EC (1);

— meat products: the meat products defined by Directive 77/99/EEC (2);

— the processed animal protein referred to in Directive 92/118/EEC;

— the bovine intestines referred to in Article 2(b) subparagraph (v) of Directive 77/99/EEC.

(a) When the abovementioned products of animal origin, containing material from bovine, ovine or caprine
animals are imported into the Community after 31 March 2001 from third countries or regions thereof, the
health certificates shall be accompanied by a declaration signed by the competent authority of the country of
production, worded as follows:

‘The product of animal origin does not contain, and is not derived from any product referred to in Chapter F
of Annex IX to Regulation (EC) No 999/2001 of 22 May 2001 laying down rules for the prevention, control
and eradication of certain transmissible spongiform encephalopathies, nor from specified risk material as
defined in Annex V to that Regulation, produced after 31 March 2001, or mechanically recovered meat
obtained from bones of the head or vertebral column of bovine, ovine or caprine animals, produced after 31
March 2001. After 31 March 2001 the animals have not been slaughtered after stunning by means of gas
injected into the cranial cavity or killed by the same method or slaughtered by laceration after stunning of
central nervous tissue by means of an elongated rod-shaped instrument introduced into the cranial cavity.’

(1) Council Directive 94/65/EC of 14 December 1994 laying down the requirements for the production and placing on the market of

minced meat and meat preparations (OJ L 368, 31.12.1994, p. 10).

(2) Council Directive 77/99/EEC of 21 December 1976 on health problems affecting intra-Community trade in meat products (OJ L 26,

31.1.1977, p. 85). Directive as last amended by Council Directive 97/76/EC (OJ L 10, 16.1.1998, p. 25).

31.5.2001

EN

Official Journal of the European Communities

L 147/39

(b) Any reference to ‘products of animal origin’ designates products of animal origin listed in this point and does
not concern other products of animal origin containing or derived from those products of animal origin.

6. Point 5 shall only apply to imports from third countries:

(a) which have not submitted to the Commission a file in support of their request for exemption from these

provisions;

(b) which have submitted such a file in which the result of evaluation of the risks determining all the potential risk

factors is nonetheless not satisfactory.

7. Member States shall carry out frequent official inspections to verify the correct application of this Annex and shall
ensure that measures are taken to avoid any contamination, particularly in slaughterhouses, cutting plants, animal
waste processing plants, high-risk processing plants or premises approved by the Member States in accordance with
Article 7 of Directive 90/667/EEC, points of sale to the consumer, landfill sites and other facilities for storage or
incineration. Member States shall

in particular set up a system to ensure and check that:

(a) specified risk material used in the production of products referred to in Article 1(2) are used solely for authorised

purposes;

(b) specified risk material, especially where the removal takes place at establishments or premises other than
slaughterhouses, is completely separated from other waste not intended for incineration, is collected separately
and is disposed of in accordance with point l and points 8 to 11. Member States may decide to allow dispatch of
heads or carcasses containing specified risk material to another Member State after that other Member State has
agreed to receive the material and has approved the specific conditions applicable to such transport.

8. Member States shall ensure that specified risk material

is removed at:

(a) slaughterhouses;

(b) cutting plants, high-risk processing plants or premises referred to in Articles 3 and 7 of Directive 90/667/EEC,
under the supervision of a designated agent appointed by the competent authority. Those establishments shall be
approved for that purpose by the competent authority.

However, the vertebral column may be removed at points of sale to the consumer situated in their territory.

Where specified risk material
is not removed from dead animals which have not been slaughtered for human
consumption, the parts of the body containing specified risk material or the entire body must be treated as specified
risk material.

9. Member States shall ensure that all specified risk material

is stained with a dye and, as appropriate, marked

immediately on removal, and completely destroyed:

(a) by incineration without pre-processing; or,

(b) provided that the dye or marking remains detectable, after pre-processing:

(i) in accordance with the systems described in Chapters I to IV, VI and VII of the Annex to Decision

92/562/EEC:

— by incineration;

— by co-incineration;

(ii) in accordance at least with the standards set out in Annex I to Council Decision 1999/534/EC, by burial in an

approved landfill site.

10. Member States may derogate from the provisions of points 8 and 9 to allow the incineration or burial of specified
risk material or entire bodies, without prior staining, or, as appropriate, without removal of the specified risk
material, in the circumstances set out in Article 3(2) of Directive 90/667/EEC and by a method which precludes all
risk of transmission of a TSE and is approved and verified by the competent authority, in particular where animals
have died or have been killed in the context of disease control measures.

11. Member States may despatch specified risk material or the material processed therefrom to other Member States for
incineration under the conditions laid down in Article 4(2) of Commission Decision 97/735/EC, where applicable.

This point may be amended at the request of a Member State to allow the dispatch of specified risk material or the
material processed therefrom to third countries for incineration, conditions governing such export having been
adopted.

L 147/40

EN

Official Journal of the European Communities

31.5.2001

B. Concerning statistical surveys

The statistical survey referred to in Article 22 must cover all animals referred to in Annex III, Chapter A, Section I, points
1.1 and 1.2.

This provision, applicable for a period of one year, may be reviewed in the light of experience gained in the first six
months.